netFormulary
 Report : A-Z of formulary items 14/08/2020 08:14:02
[Back]
 
Section Name Details
14.04 23-valent pneumococcal polysaccharide vaccine 
13.08.01 5-Aminolaevulinic acid Ameluz®

Restricted Item Dermatology only

15.03 5-aminolevulinic acid Gliolan®

For visualisation of malignant tissue during surgery for malignant glioma

05.03.01 Abacavir 
05.03.01 Abacavir/lamivudine Kivexa®
05.03.01 Abacavir/lamivudine/zidovudine Tizivir®
10.01.03 Abatacept Orencia®
02.09 Abciximab 
08.01.05 Abemaciclib Verzenios®
08.03.04.02 Abiraterone 
04.10.01 Acamprosate Campral EC®
03.12 Acapella Choice® 

Oscillating Positive Expiratory Pressure (OPEP) device.

Third-line, for patients unsuitable for PARI O-PEP or Aerobika device.

Restricted Item For initiation by specialist physiotherapist or respiratory clinician only. For airways clearance in selected patients with chronic sputum-producing lung disease, e.g. cystic fibrosis, bronchiectasis, COPD.

All follow up and monitoring of patients, and routine replacement of devices to be carried out in secondary care. 

Primary care prescribing on FP10 only when required for urgent supply of additional/replacement device (Drug Tariff listed approved appliance).

 

06.01.02.03 Acarbose 
11.06 Acetazolamide 
11.06 Acetazolamide  
12.01.01 Acetic acid 2% Earcalm ®

A first-line option for acute otitis externa (refer to South Central Antimicrobial Network Guidelines for Antibiotic Prescribing in the Community 2018) 

Self Care Self Care Medicine

13.11.01 Acetone BP 
11.08.02 Acetylcholine chloride 1% Miochol-E®
03.07 Acetylcysteine 

unlicensed Off-label use of injection.

Restricted Item Specialist initiation only for idiopathic pulmonary fibrosis.

03.07 Acetylcysteine NACSYS®

Restricted Item Specialist initation only for idiopathic pulmonary fibrosis

18 Acetylcysteine Parvolex
11.08.01 Acetylcysteine (with hypromellose) Ilube®
05.03.02.01 Aciclovir 
05.03.02.01 Aciclovir 
11.03.03 Aciclovir 3% 
13.10.03 Aciclovir 5% 

note Can be purchased OTC for cold sores.

13.05.02 Acitretin 

Restricted Item Specialist prescribing only

03.01.02 Aclidinium Eklira Genuair®

note Prescribing by brand name recommended

Licensed for COPD only, not for asthma

03.01.04 Aclidinium and formoterol  Duaklir Genuair®

note Prescribing by brand name recommended

18 Activated charcoal 
01.05.03 Adalimumab/ adalimumab biosimilar Humira®, Imraldi®, Amgevita®) (Gastroenterology

Specify brand.

Severe Crohn’s disease if failed on infliximab

Imraldi and Amgevita are black triangle.

10.01.03 Adalimumab/ adalimumab biosimilar Humira®, Imraldi®, Amgevita® ) (Rheumatology

Specify brand

Imraldi and Amgevita are black triangle

11.04 Adalimumab/ adalimumab biosimilar Humira®, Imraldi®, Amgevita®) (Ophthalmology

Specify brand.

NHS England Specialised Commissioning

 For uveitis

unlicensed Imraldi and Amgevita not licensed for paediatric uveitis. Use Humira brand for children.

Imraldi and Amgevita are black triangle

13.05.03 Adalimumab/ adalimumab biosimilar Humira®, Imraldi®, Amgevita®) (dermatology

note Specify brand.

Restricted Item Specialist centres only for moderate to severe hidradenitis suppurativa - commissioned by NHS England in accordance with NICE TA392.

Amgevita and Imraldi are black triangle

13.06.01 Adapalene 0.1% 
13.06.01 Adapalene and benzoyl peroxide Epiduo®

note  Mild to moderate papulopustular acne: Epiduo 0.1% gel (adapalene 0.1%/benzoyl peroxide 2.5%)

note  Moderate to severe papulopustular acne: Epiduo 0.3% gel (adapalene 0.3%/benzoyl peroxide 2.5%)

05.03.03.01 Adefovir Dipivoxil 
02.03.02 Adenosine Adenocor®
03.04.03 Adrenaline / Epinephrine 
03.04.03 Adrenaline / epinephrine 

Prescribe by brand name (Emerade/Epipen/Jext)

for IM self administration

02.07.03 Adrenaline 1 in 10,000 
03.12 Aerobika® 

Oscillating Positive Expiratory Pressure (OPEP) device.

Second-line, for patients unsuitable for PARI O-PEP device.

Restricted Item For initiation by specialist physiotherapist or respiratory clinician only. For airways clearance in selected patients with chronic sputum-producing lung disease, e.g. cystic fibrosis, bronchiectasis, COPD.

All follow up and monitoring of patients, and routine replacement of devices to be carried out in secondary care. 

Primary care prescribing on FP10 only when required for urgent supply of additional/replacement device (Drug Tariff listed approved appliance).

 

03.01.05 AeroChamber Plus ® 
08.01.05 Afatinib 
11.08.02 Aflibercept  
04.03.04 Agomelatine 

Restricted Item  For use within Southern Health. Initiated or recommended by a psychiatrist.

A third line option where adverse effects of alternative antidepressants make them unacceptable to patients (sexual dysfunction and sleep disturbance)

02.03.02 Ajmaline 

unlicensed unlicensed

Restricted Item Cardiology use only. For provocative challenge in Brugada Syndrome

05.05 Albendazole 

unlicensed unlicensed

13.11.01 Alcohol 70% 

From NHS Logistics.

08.01.05 Alectinib Alecensa®
08.02.04 Alemtuzumab 

For multiple sclerosis and used off-label for allogeneic BMT and peripheral blood SCT

06.06.02 Alendronic acid 

Restricted Item Not a first line option.

For use only in patients unable to swallow conventional bisphosphonate tablets, and unwilling/unsuitable for treatment with parenteral options.

06.06.02 Alendronic acid 
09.06.04 Alfacalcidol One-Alpha®
A2.03.01 Alfamino® 

Ordered through main stores

400g

04.07.02 Alfentanil 
15.01.04.03 Alfentanil 

Restricted Item Use outside of theatres for palliative care only

02.12 Alirocumab Praluent®
13.05.01 Alitretinoin 

Restricted Item Specialist prescribing only.

Routinely reimbursed by CCG if NICE TA177 eligibility criteria fulfilled.

IFR application required for exceptional use.

10.01.04 Allopurinol 
04.07.04.01 Almotriptan 

Second line oral triptan

06.01.02.03 Alogliptin 
09.06.05 Alpha Tocopheryl Acetate Vitamin E

Injection is unlicensed unlicensed

07.04.05 Alprostadil  Viridal Duo®; Caverject®

Viridal Duo® brand preferred for initiation at UHS.

note Annotate FP10 prescriptions with 'SLS' for erectile dysfunction

02.10.02 Alteplase Actilyse®

Also for pulmonary emboli

13.12 Aluminium chloride hexahydrate 20% 

Self Care Self Care Medicine. Can be purchased OTC.

09.05.02.02 Aluminium Hydroxide Alu-Cap®
04.09.01 Amantadine 
02.05.01 Ambrisentan 

For patients managed under a shared care agreement with the Royal Brompton Hospital only

10.02.01 Amifampridine base (3,4-diaminopyridine) 

unlicensed unlicensed

For Lambert-Eaton myasthenic Syndrome

05.01.04 Amikacin 
02.02.03 Amiloride Hydrochloride 
03.01.03 Aminophylline  
03.01.03 Aminophylline 

MR tab for existing patients only

02.03.02 Amiodarone 
02.03.02 Amiodarone 
04.02.01 Amisulpride 
04.03.01 Amitriptyline 

May also be used off-label for hypersalivation

04.07.03 Amitriptyline 

For neuropathic pain in accordance with NICE Guidelines

unlicensed Off-label use

04.07.04.02 Amitriptyline 

Off label use

02.06.02 Amlodipine 

For hypertension; or angina if on betablocker

13.10.02 Amorolfine 5% 

note For mild, distal fungal nail injections in up to 2 nails.

Can be purchased OTC (Pharmacy only).

05.01.01.03 Amoxicillin 

Red for patients with chronic low back pain associated with Modic type 1 changes

05.02.03 Amphotericin 
05.02.03 Amphotericin e.g. Abelcet® AmBisome®

Specify brand

11.03.02 Amphotericin 

unlicensed unlicensed

09.01.04 Anagrelide Xagrid®

Restricted Item Consultant haematologist recommendation only

10.01.03 Anakinra Kineret®

Restricted Item Restricted as per commissioning policies. 

08.03.04.01 Anastrozole 
12.03.01 Antacid with oxetacaine 

unlicensed unlicensed special

Restricted Item For treatment of symptoms of oral mucositis and oesophageal lesions causing painful swallowing when recommended by cancer care specialist only.

Replaces Mucaine suspension (discontinued)

11.04.02 Antazoline with xylometazoline Otrivine-Antistin®
14.05.03 Anti-D (Rh0) Immunoglobulin 
08.02.02 Antithymocyte immunoglobulin (rabbit)  
01.07.01 Anusol ® 

Self Care Self Care Medicine

01.07.02 Anusol-HC 
02.08.02 Apixaban Eliquis®)(AF/VTE
02.08.02 Apixaban Eliquis®)(Orthopaedic prophylaxis
04.09.01 Apomorphine 

Consultant initiated in severe disease

11.08.02 Apraclonidine Iopidine®

note Note: different licensed indications for different strengths (refer to SPCs).

1% unit dose eye drops are preservative-free.

10.01.03 Apremilast 
13.05.03 Apremilast 
04.06 Aprepitant Emend®

For chemotherapy-induced nausea/vomiting

Liquid for chemotherapy-induced nausea/vomiting in children 6months - 12years

02.11 Aprotinin Trasylol®

Restricted Item Restricted to use by Cardio-thoracic anaesthetist only

A2.03.01 Aptamil® 1 

Ordered through main stores

900g

A2.03.01 Aptamil® 1 ready to feed 

Ordered through main stores

A2.03.01 Aptamil® Pepti 1 

Ordered via main stores

13.02.01 Aqueous Cream  

note Not recommended by dermatology specialists. Consider alternative emollients, e.g. ZeroAQS (does not contain SLS).

01.06.03 Arachis Oil 
02.08.01 Argatroban Exembol®

Option for patients in critical care areas with heparin-induced thrombocytopenia

04.02.01 Aripiprazole 
04.02.02 Aripiprazole Abilify Maintena®

Restricted Item Secondary psychiatric care only

note For intramuscular injection

04.02.01 Aripiprazole 7.5mg/ml Abilify®

Restricted Item Specialist use only by Southern Health in accordance with rapid tranquilisation guidelines.

08.01.05 Arsenic trioxide 
05.04.01 Artemether with lumefantrine 

For acute uncomplicated P.falciparum malaria or as oral step down treatment following IV artesunate

05.04.01 Artesunate 

unlicensed unlicensed

Restricted Item for severe or complicated P.falciparum malaria

09.06.03 Ascorbic Acid Vitamin C
09.06.03 Ascorbic Acid Vitamin C

Effervescent tablet for mouthcare only

02.09 Aspirin 
02.09 Aspirin  

unlicensed injection is unlicensed 

04.07.01 Aspirin 

EC tablets are not formulary

04.07.04.01 Aspirin 

Soluble or dispersible form preferred +/- metoclopramide

10.02 Ataluren Translarna®

For use in line with NHSE specialised commissioning criteria

05.03.01 Atazanavir 
05.03.01 Atazanavir sulfate/cobicistat Evotaz®

As per NHSE specialised commissioning circular 1614

02.04 Atenolol 
02.04 Atenolol 
08.01.05 Atezolizumab 
04.04 Atomoxetine Strattera®
02.12 Atorvastatin 
07.01.03 Atosiban 
05.04.08 Atovaquone 
11.05 Atropine multi-dose bottle

Restricted Item Hospital only. High cost in primary care - use Minims formulation.

11.05 Atropine Minims®

Preferred formulation in primary care.

Preservative-free.

May also be used off-label by sublingual administration for hypersalivation.

15.01.03 Atropine  
08.01.05 Avelumab 
07.04.05 Aviptadil + phentolamine Invicorp®

Specialist initiation. Second line to alprostadil

08.01.05 Axitinib 
08.01.03 Azacitidine 
08.02.01 Azathioprine 

unlicensed Liquid is unlicensed

08.02.01 Azathioprine 
10.01.03 Azathioprine 

unlicensed unlicensed liquid

13.05.03 Azathioprine dermatology
13.06.01 Azelaic acid 20% Skinoren®

note Alternative if benzoyl peroxide not tolerated

12.02.01 Azelastine and fluticasone Dymista

Third line therapy for allergic rhinitis where response to treatment with other therapies, including combination of oral antihistamines and intranasal corticosteroids, was inadequate or not tolerated

05.01.05 Azithromycin 
05.01.05 Azithromycin 
11.03.01 Azithromycin 

Restricted Item Ophthalmology only

05.01.02.03 Aztreonam 

To be used in line with NHSE specialised commissioning policy

03.01.05 Babyhaler® 
10.02.02 Baclofen 
11.09 Balanced salt solution 
11.99.99.99 Balanced salt solution 
10.01.03 Baricitinib Olumiant®
08.02 Basiliximab Simulect®
08.02.04 BCG bladder instillation 
14.04 BCG vaccine diagnostic agent 

unlicensed unlicensed

14.04 BCG vaccine Intradermal 
03.02 Beclometasone and formoterol Fostair®

note Prescribing by brand name recommended

200/6 strength licensed for asthma only, not for COPD

03.02 Beclometasone dipropionate 

Red Triangle MHRA Drug Safety Update July 2008: prescribe CFC-free beclometasone metered-dose inhalers by brand name to reduce the risk of dosing errors

Note: Potencies and dosing recommendations may vary between brands. Refer to product SPC or BNF for more detailed advice.

MDI brands of choice in the Southampton locality are Soprobec (equivalent to Clenil brand) and Kelhale (equivalent to Qvar brand).

unlicensed Kelhale brand is not licensed in children under 18 years.

 

12.02.01 Beclometasone Dipropionate 

First line for adults in nasal allergy

03.02 Beclometasone/formoterol/glycopyrronium  Trimbow®

note Prescribing by brand name recommended

05.01.09 Bedaquiline Sirturo®

Restricted Item For specialist use only in line with NHS Engand Clinical Commissioning Policy (170132P).

03.04.02 Bee and Wasp Allergen Extracts 
10.01.03 Belimumab Benlysta®
08.01.01 Bendamustine 
02.02.01 Bendroflumethiazide 
04.02.01 Benperidol Anquil®

Restricted Item Southern Health use only

03.04.02 Benralizumab Fasenra®
05.01.01.01 Benzathine benzylpenicillin 

Restricted Item Special Use by Sexual Health Clinics (Solent NHS Trust) ONLY 

For treatment of syphilis as recommended in BASHH Guidelines 2015

note The preparation is strictly for deep intramuscular injection

03.08 Benzoin tincture, compound 
13.06.01 Benzoyl Peroxide 

Self Care Self Care Medicine

12.03.01 Benzydamine Difflam®

Self Care Available OTC

05.01.01.01 Benzylpenicillin sodium Penicillin G
03.05.02 Beractant 
04.06 Betahistine Dihydrochloride 

For prophylaxis in proven Ménière’s disease

09.08.01 Betaine 

unlicensed unlicensed

06.03.02 Betamethasone 

For use as a mouthwash only

06.03.02 Betamethasone 
11.04.01 Betamethasone  
12.01.01 Betamethasone 0.1% 
12.01.01 Betamethasone 0.1% with neomycin 0.5% Betnesol N®

A first-line option for acute otitis externa (refer to South Central Antimicrobial Network Guidelines for Antibiotic Prescribing in the Community 2018) 

12.03.01 Betamethasone 500microgram 

unlicensed Use for treatment of oral ulceration or inflammation is off label. For use as a mouthwash only - not to be swallowed.

11.04.01 Betamethasone and neomycin  Betnesol N®
13.04 Betamethasone dipropionate 0.05% with salicylic acid 2% Diprosalic®
13.04 Betamethasone dipropionate 0.05% with salicylic acid 3% Diprosalic®
12.02.01 Betamethasone eye/ear/nose drops 
13.04 Betamethasone valerate 0.025% Betnovate-RD®
13.04 Betamethasone valerate 0.1% Betacap®
13.04 Betamethasone valerate 0.1% 
13.04 Betamethasone valerate 0.1% with fusidic acid 2% Fucibet®

note For short-term use

13.04 Betamethasone valerate 0.1% with neomycin 0.5% 

note For short-term use

11.06 Betaxolol 

Not a first line choice. 

Restricted Item Unit dose drops only for patients allergic/intolerant of preservative, or high risk of developing allergy

08.01.05 Bevacizumab Avastin®

For use in line with CDF criteria.

Restricted Item Commissioned by NHS England for neurofibromatosis by NHS England as per national protocol (see NF2 service specification) at specialist centres only.

02.12 Bezafibrate 

Consider only when a statin or other treatments are contra-indicated or not tolerated

unlicensed Also approved for off-label use for the treatment of primary biliary cholangitis

08.03.04.02 Bicalutamide 
05.03.01 Bictegravir / emtricitabine / tenofovir-alafenamide Biktarvy ®

Specialist only, in line with NHSE Clinical Commissioning Policy 170131P

11.06 Bimatoprost 

Not a first line choice

Restricted Item Unit dose drops only for patients allergic/intolerant of preservatives, or high risk of developing allergy

11.06 Bimatoprost with timolol Ganfort®

Not a first line choice

Restricted Item Unit dose drops only for patients allergic/intolerant of preservatives, or high risk of developing allergy

12.03.05 Biotene Oralbalance ® 
06.01.01.02 Biphasic Insulin Aspart NovoMix® 30
06.01.01.02 Biphasic Insulin Lispro Humalog® Mix
06.01.01.02 Biphasic Isophane Insulin Humulin® M3
06.01.01.02 Biphasic Isophane Insulin 25 Insuman® Comb 25
12.04 BIPP gauze 
01.06.02 Bisacodyl 
02.04 Bisoprolol 

Heart failure - first line

02.08.01 Bivalirudin Angiox®
08.01.02 Bleomycin 
08.01.05 Blinatumomab 
07.02.02 Boric acid  

unlicensed unlicensed

Restricted Item Specialist use by sexual health clinics (Solent NHS Trust) ONLY.

Treatment of chronic/recurrent vaginal candida for which other treatments (inc.azoles,clotrimazole and nystatin) have failed

08.01.05 Bortezomib 
02.05.01 Bosentan Tracleer®

For patients managed under a shared care agreement with the Royal Brompton Hospital only

08.01.05 Bosutinib 
14.04 Botulinum antitoxin 

Specialist clinics only

01.02 Botulinum neurotoxin type A  Xeomin®
01.07.04 Botulinum toxin type A 

unlicensed unlicensed for anal fissures

Specify brand

04.07.04.02 Botulinum Toxin Type A 

Specify brand

04.09.03 Botulinum Toxin Type A 

Specify brand and indication

Restricted Item Restricted use - discuss with directorate pharmacist

13.12 Botulinum toxin type A  

Restricted Item Dermatology only. For severe hyperhidrosis.

08.01.05 Brentuximab vedotin 
08.01.05 Brigatinib Alunbrig®
11.06 Brimonidine 
13.06.01 Brimonidine 

note For patients with rosacea who have failed to respond to, or are intolerant of, other options, or have psychological distress due to persistent redness.

11.06 Brimonidine with timolol 
11.06 Brinzolamide 
11.06 Brinzolamide with brimonidine Simbrinza®

Not a first line option

11.06 Brinzolamide with timolol Azarga®

Not a first line option

04.08.01 Brivaracetam Briviact®

Restricted Item For specialist initiation. Use restricted to selected patients. (e.g. inadequate seizure control or where other antiepileptic drugs are contraindicated, not tolerated or inappropriate)

13.05.03 Brodalumab 
04.09.01 Bromocriptine 

Not a first line option in Parkinson’s disease

06.07.01 Bromocriptine 
01.05.02 Budesonide Budenofalk®

For ileo-caecal disease

01.05.02 Budesonide Cortiment®

For ulcerative colitis

01.05.02 Budesonide 
03.02 Budesonide 

note Prescribing by brand name recommended

03.02 Budesonide and formoterol 

note Prescribing by brand name recommended

02.02.02 Bumetanide 
15.02 Bupivacaine 0.1% and fentanyl 2microgram/ml epidural 

Restricted Item Obstetrics only

15.02 Bupivacaine 0.15% and fentanyl 2microgram/ml epidural 
15.02 Bupivacaine Hydrochloride 

0.125%, 0.25% and 0.5%

15.02 Bupivacaine Hydrochloride 5mg with Glucose 80mg/ml Marcain Heavy®
04.10.03 Buprenorphine 

Not initiated in UHS

04.10.03 Buprenorphine Espranor®

Not initiated in UHS

Red Triangle Espranor is not interchangeable with other buprenorphine products.

04.07.02 Buprenorphine 35-70microgram/hour 96hour patch 

Prescribe by brand name

04.07.02 Buprenorphine 5-20microgram/hour weekly patch 

Prescribe by brand name

04.10.03 Buprenorphine and Naloxone Suboxone®

Not initiated in UHS

04.10.02 Bupropion Hydrochloride Zyban®

As part of a smoking cessation programme.

09.08.01 Burosumab Crysvita®

Restricted Item Specialist use only in accordance with NICE HST8 guidance 

06.07.02 Buserelin 
04.01.02 Buspirone Hydrochloride 
08.01.01 Busulfan 

injection for BMT only

03.04.03 C1 esterase inhibitor Berinert®

Restricted Item For use as per commissioning criteria set by NHS England

03.04.03 C1 esterase inhibitor Cinryze®

Restricted Item For use as per commissioning criteria set by NHS England

Restricted Item Homecare use only

08.01.05 Cabazitaxel 
04.09.01 Cabergoline 

Not a first line option in Parkinson’s disease

06.07.01 Cabergoline 500microgram Dostinex®

Hyperprolactinaemia

08.01.05 Cabozantinib Cabometyx®
13.05.02 Cade oil & salicylic acid  

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

03.01.03 Caffeine citrate 

Restricted Item Neonatal unit only

13.03 Calamine BP 
13.05.02 Calcipotriol 50mcg/g 
13.05.02 Calcipotriol with betamethasone  
06.06.01 Calcitonin (salmon) / Salcatonin 
09.06.04 Calcitriol 
09.05.02.02 Calcium acetate and magnesium carbonate, heavy Osvaren®

For hyperphosphataemia of chronic renal failure in patients undergoing dialysis

09.06.04 Calcium and colecalciferol (vitamin D3) 

Chewable tablets first-line. Effervescent and film-coated tablets reserved to aid administration in those unable to take chewable tablets. 

Note that different formulations have different amounts of colecalciferol and calcium.

Choose brand with lowest acquisition cost and prescribe by brand name to avoid confusion. 

Preferred brands in primary care: Accrete D3 or TheiCal D3

09.05.01.01 Calcium carbonate 

Chewable tablets first-line.

Effervescent tablets reserved to aid administration in those unable to take chewable tablets. 

Choose brand with lowest acquisition cost and prescribe by brand name to avoid confusion.

Refer to section 9.6.4 for calcium and vitamin D3.

09.05.02.02 Calcium carbonate  

unlicensed unlicensed

09.05.02.02 Calcium Carbonate Adcal®
09.05.01.01 Calcium carbonate and calcium lactate gluconate  Calvive 1000®

note  Formerly Sandocal®

Chewable tablets first line.

09.05.01.01 Calcium Chloride 
08.01 Calcium Folinate 

folinic acid rescue

09.05.01.01 Calcium Gluconate 
18 Calcium gluconate 2.5% gel/10% injection 
09.05.01.01 Calcium lactate + calcium gluconate  Alliance Calcium Syrup®

0.51mmol/ml of Calcium

Specialist recommendation for paediatric patients only.

Licensed as a nutritional supplement, not a medicine.

Primary care to prescribe by brand name.

09.02.01.01 Calcium polystyrene sulfonate Calcium Resonium®

note Powder for oral or rectal suspension

A2.04.01.02 Calogen ®  

Not held in stock but available to order through pharmacy

200ml/500ml 

Strawberry/Neutral

A2.04.01.02 Calogen Extra® 

6 x 40ml stocked in pharmacy

13.07 Camellia sinensis (green tea) leaf extract Catephen 10% ®

Restricted Item For use by sexual health clinics (Solent NHS Trust) ONLY

For the cutaneous treatment of external genital and perianal warts in immunocompetent patients (adults) when other treatments have failed

13.08.02 Camouflage cosmetics 

Restricted Item As advised by specialist service.

Borderline substances (ACBS).

06.01.02.03 Canagliflozin 
02.05.05.02 Candesartan 
04.08.01 Cannabidiol Epidyolex®

Restricted Item Registered specialist only. See NICE NG144 (section 1.5) for details on who should prescribe.

10.02.02 Cannabis extract Sativex®

Restricted Item Restricted use.

Use is supported only for spasticity in patients with multiple sclerosis in accordance with NICE guidelines NG144.

Must be initiated and supervised by a physician with specialist expertise in treating spasticity due to multiple sclerosis.

For secondary care prescribing only until shared care guidelines have been developed and approved.

13.09 Capasal® Therapeutic 

note Salicylic acid 0.5% w/w; coconut oil 1% w/w; distilled coal tar 1% w/w.

08.01.03 Capecitabine 
10.03.02 Capsaicin Qutenza®

Restricted Item Only for post herpetic neuralgia where other pain relief is inadequate

10.03.02 Capsaicin 0.025% Zacin®
02.05.05.01 Captopril 

Restricted Item  Child Health and for patients particularly at risk of hypotension

02.05.05.01 Captopril 

Restricted Item  Child Health and for patients particularly at risk of hypotension

04.07.03 Carbamazepine 
04.08.01 Carbamazepine 

For partial seizures and secondary generalised tonic-clonic seizures

06.02.02 Carbimazole 
03.07 Carbocisteine 
11.08.01 Carbomer  polyacrylic acid

note To be used in line with DPC dry eye guidelines (link below). 

Clinitas® Gel preferred at UHS

08.01.05 Carboplatin 
07.01.01 Carboprost 
09.02.02 Cardioplegia Plegivex®
08.01.05 Carfilzomib 
11.08.01 Carmellose  Optive®/Optho-lique®

note To be used in line with DPC dry eye guidelines (link below). 

Contains a gentle preservative so may be an option if patient is allergic to commonly-used preservatives

11.08.01 Carmellose sodium 

note To be used in line with DPC dry eye guidelines (link below)

Preservative-free. Single use.

Restricted Item Only for patients allergic/intolerant of preservatives or at high risk of developing allergy

08.01.01 Carmustine 

unlicensed Injection is unlicensed

A2.05.02 Carobel, Instant ®  

Ordered via main stores

02.04 Carvedilol 

Heart failure - second line

05.02.04 Caspofungin 

Restricted Item Specialist use only

05.01.02.01 Cefaclor 
05.01.02.01 Cefalexin 
05.01.02.01 Cefazolin 

Restricted Item Use restricted to Microbiology recommendation only for MSSA bacteraemia in patients with mild penicillin allergy who are not suitable for treatment with flucloxacillin.

SPC and PIL available on MHRA website.

05.01.02.01 Cefixime 
05.01.02.01 Cefotaxime 
05.01.02.01 Cefoxitin 

unlicensed Unlicensed

Restricted Item Microbiology recommendation only for mycobactrium abcessus respiratory infection in cystic fibrosis

05.01.02.01 Ceftaroline 

Restricted Item Microbiology recommendation only

05.01.02.01 Ceftazidime 
05.01.02.01 Ceftazidime/avibactam 

Restricted Item  restricted to microbiology approval/recommendation only

05.01.02.01 Ceftolozane/tazobactam  Zerbaxa®

Restricted Item  restricted to microbiology approval/recommendation only

05.01.02.01 Ceftriaxone 
05.01.02.01 Cefuroxime 
11.03.01 Cefuroxime 

unlicensed unlicensed

Restricted Item Ophthalmology only

10.01.01 Celecoxib 
08.02.04 Cemiplimab Libtayo
08.01.05 Ceritinib 
10.01.03 Certolizumab Pegol Cimzia®
13.05.03 Certolizumab pegol Cimzia®
03.04.01 Cetirizine 
13.02.01 Cetraben® 

note Consider ExCetra cream as more cost effective alternative to Cetraben cream

Ointment also suitable for use as a soap substitute or as bath additive.

13.09 Cetrimide and undecenoic acid Ceanel Concentrate®
06.07.02 Cetrorelix Cetrotide®
08.01.05 Cetuximab 
04.01.01 Chloral Hydrate 500mg in 5mL 

unlicensed unlicensed

04.01.01 Chloral Hydrate Suppositories 

unlicensed unlicensed

08.01.01 Chlorambucil 
05.01.07 Chloramphenicol 

Restricted Item Capsules on microbiology advice only

11.03.01 Chloramphenicol  
12.01.01 Chloramphenicol 5% 
04.10.01 Chlordiazepoxide 

For alcohol withdrawl

UHS users see local guideline

11.03.01 Chlorhexidine 

unlicensed unlicensed

Restricted Item Ophthalmology only

12.03.04 Chlorhexidine  

Available over the counter in primary care

13.11.02 Chlorhexidine 

From NHS Logistics.

07.04.04 Chlorhexidine 0.02%  
13.11.03 Chlorhexidine and cetrimide Tisept®

From NHS Logistics.

13.11.03 Chlorhexidine and cetrimide 
13.11.02 Chlorhexidine gluconate 0.05% 

From NHS Logistics.

13.11.02 Chlorhexidine gluconate 0.5% 

From NHS Logistics.

13.11.02 Chlorhexidine gluconate 1% 
13.11.02 Chlorhexidine gluconate 4% 

From NHS Logistics

12.02.03 Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin®
05.04.01 Chloroquine 

Restricted Item Supported only for licensed indications (Not NHS not on NHS for malaria prevention)

 

Not for use in Covid-19 treatment/prevention outside of clinical trials (see links below). Seek further advice from infection control specialist/pharmacy team.

02.02.01 Chlorothiazide 

unlicensed unlicensed

Restricted Item Child Health only

03.04.01 Chlorphenamine 
04.02.01 Chlorpromazine 
12.03.01 Choline salicylate Bonjela®

Self Care Available OTC 

Red Triangle For adults and children over 16 years only

06.05.01 Choriogonadotropin Alfa 
06.05.01 Chorionic Gonadotrophin HCG
03.02 Ciclesonide 

Restricted Item  Specialist initiation only. For add on treatment in severe asthma as a steroid sparing agent.

08.02.02 Ciclosporin 

Red Red for renal transplant
Amber Amber for all other indications

Specify brand

08.02.02 Ciclosporin 
10.01.03 Ciclosporin 

Specify brand

13.05.03 Ciclosporin dermatology

Prescribe by brand name

11.04.02 Ciclosporin 0.1% Verkazia®

1mg/ml.

Restricted Item Ophthalmology specialist initiation. Prescribe by brand name (different licensed indication to Ikervis® brand).

11.08.01 Ciclosporin 0.1% Ikervis®

1mg/ml

Prescribe by brand name (different licensed indication to Verkazia<sup>®</sup>brand)

11.08.01 Ciclosporin 0.2% 

Restricted Item unlicensed Unlicensed formulation. Restricted use - only when licensed formulation not suitable or unavailable.

05.03.02.02 Cidofovir  

Restricted Item For use as per commissioning criteria set by NHS England

01.03.01 Cimetidine 

Restricted Item For palliative care use only, or as an alternative H2-antagonist when ranitidine is not available, and a proton pump inhibitor is not suitable. 

Red Triangle Check for interactions before prescribing.

 

09.05.01.02 Cinacalcet Mimpara®

Restricted Item Endocrinologist use only

04.06 Cinnarizine 

For labyrinthine vertigo or acute treatment of Ménière’s disease

05.01.12 Ciprofloxacin 
05.01.12 Ciprofloxacin 
12.01.01 Ciprofloxacin 0.3% with dexamethasone 0.1% Cilodex®

Second line when aminoglycosides should not be used.

12.01.02 Ciprofloxacin 0.3% with dexamethasone 0.1% Cilodex®

Second line where aminoglycosides should not be used

15.01.05 Cisatracurium Nimbex®
08.01.05 Cisplatin 
04.03.03 Citalopram 

Tablets and oral drops are not dose-equivalent

08.01.03 Cladribine 
10.02 Cladribine Mavenclad®
05.01.05 Clarithromycin 
05.01.06 Clindamycin 

unlicensed Liquid is unlicensed

05.01.06 Clindamycin  
05.04.08 Clindamycin  

In combination with primaquine (off-label use)

unlicensed Liquid is unlicensed

07.02.02 Clindamycin 
13.06.01 Clindamycin 1% 
13.06.01 Clindamycin 1% and tretinoin 0.025% 
13.06.01 Clindamycin with benzoyl peroxide  Duac® Once Daily
04.08.01 Clobazam 
13.04 Clobetasol propionate 0.05% 
13.04 Clobetasol propionate 0.05% with neomycin and nystatin 

note Prescribe as generic - Dermovate-NN brand discontinued

13.04 Clobetasone butyrate 0.05% Eumovate®
13.04 Clobetasone butyrate 0.05% with oxytetracycline 3% and nystatin Trimovate®

Restricted Item Not usually a first-line treatment option. For short-term use only in accordance with product licence (refer to SPC) for treatment of steroid responsive dermatoses where candidal and/or bacterial infection is present, suspected or likely to occur.

Note: nystatin is not effective against dermatophytes and risk of resistance with overuse of topical antibiotics.

 

Black Not supported locally for off label use in chronic wound management (see below)

05.01.09 Clofazimine 

unlicensed Unlicensed

Restricted Item Specialist microbiology/TB service recommendation only

04.01.01 Clomethiazole Heminevrin®
06.05.01 Clomifene citrate 
04.03.01 Clomipramine 
04.01.02 Clonazepam 

Restricted Item Southern Health only

04.08.01 Clonazepam 
04.08.02 Clonazepam 

unlicensed unlicensed

02.05.02 Clonidine 

Amber Recommended Amber Recommended for licensed indications (refer to SmPC for details).

Red Restricted Item unlicensed for short-term, off label use in sedation/opioid withdrawal in high care paediatrics in accordance with UHS protocol

02.05.02 Clonidine Catapres®
02.05.02 Clonidine 50micrograms in 5ml 

Restricted Item unlicensed for short-term, off label use in sedation/opioid withdrawal in high care paediatrics in accordance with UHS protocol; oral solution only for use when tablet formulation not suitable

 

02.09 Clopidogrel 
07.02.02 Clotrimazole 
12.01.01 Clotrimazole 1% 
13.10.02 Clotrimazole 1% 

note Can be purchased OTC.

04.02.01 Clozapine 

Restricted Item Specialist use only for treatment resistant schizophrenia

13.05.02 Coal tar Psoriderm®
13.09 Coal tar 4% Polytar®
13.05.02 Coal tar 5% Exorex®
13.05.02 Coal tar BP 

2%, 5% and 10%

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.09 Coal tar extract 5% (alcoholic) Alphosyl 2 in 1®
13.05.02 Coal tar solution BP 3.3% with propylene glycol 20% 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.05.02 Coal tar solution BP 5% 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.05.02 Coal tar solution BP 6% & salicylic acid 2% Coal tar Scalp Pomade

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.05.02 Coal tar solution BP 6% & salicylic acid 6% 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.05.02 Coal tar, salicylic acid & sulphur Sebco ®
02.02.04 Co-amilofruse (furosemide and amiloride) 

Only as an aid to compliance

05.01.01.03 Co-Amoxiclav 
04.09.01 Co-Beneldopa 
05.03.01 Cobicistat Tybost®

Restricted Item Specialist only, in line with NHSE Clinical Commissioning Policy F03/P/b

11.07 Cocaine 

unlicensed unlicensed

12.03.01 Cocaine 5% 

unlicensed Unlicensed

15.02 Cocaine 5% 
04.09.01 Co-Careldopa Duodopa®

Restricted Item For use as per specialist commissioning criteria set by NHS England

04.09.01 Co-Careldopa 
04.09.01 Co-Careldopa with Entacapone 
13.05 Coconut oil 25% 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.06.02 Co-cyprindiol 
01.06.02 Co-danthramer 

Only for constipation in terminal illness

01.06.02 Co-danthrusate 

Only for constipation in terminal illness

03.09.01 Codeine Linctus BP 
01.04.02 Codeine phosphate 
04.07.02 Codeine Phosphate 

unlicensed unlicensed suppositories

10.01.04 Colchicine 

Second line

09.06.04 Colecalciferol Vitamin D3

note Products that are UK licensed medicines should be prescribed and supplied wherever possible

01.09.02 Colesevelam 

unlicensed  Restricted Item Second line to colestyramine for treatment of diarrhoea associated with bile acid malabsorption (off label use) - specialist diagnosis and recommendation only

01.09.02 Colestyramine powder 
02.12 Colestyramine powder 
05.01.07 Colistimethate  
05.01.07 Colistimethate 

Restricted Item Cancer care only, for gut sterilisation prior to BMT

05.01.07 Colistimethate 

injection can be nebulised

10.03.01 Collagenase Xiapex®

Limited usage - contact Care Group Pharmacist

01.01.01 Co-magaldrox Mucogel®

First line option in primary care

06.04.01.01 Combined continuous HRT patch Evorel® Conti
06.04.01.01 Combined cyclical HRT patch Evorel® Sequi
06.04.01.01 Combined cyclical HRT tablet Elleste-Duet®
07.03.01 Combined Hormonal Contraceptives Qlaira®

Restricted Item Specialist only use for exceptionally heavy menstrual bleeding

07.03.01 Combined Hormonal Contraceptives Evra
07.03.01 Combined Hormonal Contraceptives TriNovum®

For existing patients only. No longer routinely recommended

A2.03.01 Complete amino acid mix (Nutricia®) 

Ordered through main stores

200g

09.02.02.01 Compound Sodium Lactate BP known as Hartmann's solution
03.04.03 Conestat alfa Ruconest®

Restricted Item For use as per commissioning criteria set by NHS England

12.04 Co-phenylcaine  

unlicensed Unlicensed

07.03.04 Copper intra-uterine devices 
06.05.01 Corticorelin (corticotrophin-releasing hormone) 
05.01.08 Co-trimoxazole 
05.04.08 Co-trimoxazole 
A2.03.01 Cow and Gate® 1st infant milk 

Ordered through main stores

70mls x 24

A2.03.01 Cow and Gate® Pepti-Junior 

Ordered via main stores

08.01.05 Crisantaspase 
08.01.05 Crizotinib 
13.03 Crotamiton 

note For itch after scabies

13.05.02 Crude coal tar in white soft paraffin 
09.01.02 Cyanocobalamin (vitamin B12) 

Restricted Item For use only when patients are unable to receive hydroxocobalamin injections (e.g. during COVID-19).

unlicensed Available only as nutritional supplement (refer to BNF for prescribing options).

Self Care Self Care Medicine: Patients should be recommended to self purchase unless they meet the exception criteria outlined in the NHS England Guidance on conditions for which over the counter items should not routinely be prescribed in primary care (section 4.1.2 Vitamins and Minerals)

09.01.02 Cyanocobalamin (vitamin B12) 

Restricted Item For use only when patients are unable to receive hydroxocobalamin injections (e.g. during COVID-19).

Self Care Self Care Medicine: Not usually suitable for prescribing on the NHS. Patients should be recommended to self purchase unless they meet the exception criteria outlined in the NHS England Guidance on conditions for which over the counter items should not routinely be prescribed in primary care (section 4.1.2 Vitamins and Minerals)

04.06 Cyclizine 

Green For oral, intramuscular or subcutaneous administration. Note: subcutaneous administration is off label but is established practice in palliative care. 

Red For intravenous administration. Restricted Item Due to safety concerns, intravenous use of cyclizine at UHS is restricted to short-term (i.e. single dose) only.

11.05 Cyclopentolate  

Unit dose drops preservative-free.

08.01.01 Cyclophosphamide 
05.01.09 Cycloserine 

Restricted Item Specialist microbiology/TB service recommendation only

03.04.01 Cyproheptadine 

Restricted Item Paediatric oncology only

06.04.02 Cyproterone Acetate 
08.03.04.02 Cyproterone acetate 
08.01.03 Cytarabine 
02.08.02 Dabigatran Pradaxa®) (AF/VTE
02.08.02 Dabigatran Pradaxa®) (Orthopaedic prophylaxis
08.01.05 Dabrafenib 
08.01.05 Dacarbazine 
05.03.03.02 Daclatasvir  
08.01.05 Dacomitinib  Vizimpro®

 

 

08.01.02 Dactinomycin 

unlicensed unlicensed

05.01.07 Dalbavancin 

Restricted Item For use only when recommended by microbiology/infectious disease consultant

02.08.01 Danaparoid Orgaran®

For thromboprophylaxis when history of heparin-induced thrombocytopenia

06.07.02 Danazol unlicensed import

note  For long-term prophylaxis of hereditary angioedema.

10.02.02 Dantrolene 
15.01.08 Dantrolene Sodium 

Notify consultant IMMEDIATELY diagnosis suspected

06.01.02.03 Dapagliflozin 

Green for type 2 diabetes in accordance with NICE technology appraisal guidance (see below)

Amber Recommended for type 1 diabetes in accordance with NICE technology appraisal guidance (see below)

 

07.04.06 Dapoxetine Priligy®

Restricted Item Supported by DPC Feb 2014 for use when recommended by a specialist for select patients who have failed or are not considered suitable for other treatment options.

Note: for patients with concomitant depression/anxiety, 'off label' use of SSRIs would be preferred.

05.01.10 Dapsone 
05.04.08 Dapsone 
05.01.07 Daptomycin 

Restricted Item Specialist use only

08.01.05 Daratumumab Darzalex®
09.01.03 Darbepoetin Alfa Aranesp®
07.04.02 Darifenacin 
05.03.01 Darunavir 
05.03.01 Darunavir/cobicistat Rezolsta®

As per NHSE specialised commissioning circular 1614

05.03.01 Darunavir/cobicistat/emtricitabine/tenofovir alafenamide fumarate  Symtuza®

Restricted Item Specialist only, in line with NHSE Clinical Commissioning Policy F03/P/b

05.03.03.02 Dasabuvir 
08.01.05 Dasatinib 
08.01.02 Daunorubicin 
09.01.03 Deferasirox Exjade®

For use as per commissioning criteria set by NHS England

09.01.03 Deferiprone Ferriprox®

For use as per commissioning criteria set by NHS England

02.08.01 Defibrotide 

unlicensed unlicensed

08.03.04.02 Degarelix Firmagon®
09.06.07 DEKAs Essential/DEKAs Plus 

Vitamin and mineral supplements for use when recommended by a specialist in patients with cystic fibrosis.

Specialists to ensure preferred formulation and dose is clearly communicated to primary care prescribers.

05.01.09 Delamanid Deltyba®

Restricted Item For specialist use only in line with NHS England Clinical Commissioning Policy (170132P).

05.01.03 Demeclocycline 

For the treatment of SIADH

06.06.02 Denosumab XGEVA®

metastases

06.06.02 Denosumab Prolia®

Osteoporosis.

07.02.02 Dequalinium chloride Fluomizin®

Restricted Item Specialist use by Sexual Health Clinics (Solent NHS Trust) ONLY 

For treatment of bacterial vaginosis (when other treatments have failed)

13.02.01.01 Dermalo® 

note First line bath emollient. Fragrance-free.

Also suitable for application to skin after showering.

13.02.01 Dermol® 

note Note: Contains an antimicrobial. Not recommended for long term use.

Also suitable for use as a soap substitute.

09.01.03 Desferrioxamine mesilate 
18 Desferrioxamine mesilate 
15.01.02 Desflurane Suprane®

Restricted Item For bariatric surgery

Restricted Item For use by Consultants, or on approval of a Consultant, for patients with BMI>35kg/m2 undergoing obstetric or gynaecological surgery

06.05.02 Desmopressin  Octim®

150mcg per metered dose nasal spray for Von Willebrand's disease 

06.05.02 Desmopressin 

Noqdirna® tablets are non-formulary (see below)

06.05.02 Desmopressin (DDAVP) 
07.03.02.01 Desogestrel 75 microgram 
06.03.02 Dexamethasone 

note Soluble tablets first line at UHS

06.03.02 Dexamethasone 

Green For palliative care use

Red For all other uses

11.04.01 Dexamethasone  
11.04.01 Dexamethasone intravitreal implant Ozurdex®
11.04.01 Dexamethasone, framycetin, gramicidin Sofradex®

Green for otitis externa (see section 12.1.1)

11.04.01 Dexamethasone, neomycin and polymyxin B Maxitrol®
12.01.01 Dexamethasone/framycetin/gramicidin Sofradex®

Amber for eye indications (see section 11.4.1)

12.01.01 Dexamethasone/neomycin/acetic acid Otomize®
04.04 Dexamfetamine 
15.01.04.04 Dexmedetomidine  Dexdor®

Restricted Item Neuro ICU consultant only or

Restricted Item Off-label use for awake craniotomy and paediatric laryngotracheobronchoscopy

08.01 Dexrazoxane Cardioxane®

Restricted Item Approved only for preventing cardiotoxicity in children and young people (under 25 years) receiving high-dose anthracyclines in accordance with NHS England Commissioning Policy.

 

Red Triangle Note: Savene® brand remains non-formulary

04.07.02 Diamorphine 

Restricted Item Paediatrics

04.07.02 Diamorphine 
04.01.02 Diazepam 
04.08.02 Diazepam epilepsy
10.02.02 Diazepam 
15.01.04.01 Diazepam 
06.01.04 Diazoxide 
10.01.01 Diclofenac 

Not a first line NSAID

10.01.01 Diclofenac 50mg in 5ml 

Restricted Item unlicensed Unlicensed special. Restricted use - short term use for postoperative analgesia in children. Second line to ibuprofen and only when licensed options are not suitable. 

15.01.04.02 Diclofenac sodium 75mg in 3ml 

Restricted Item Restricted to paediatric theatres only, or for adults if ketorolac injection not available.

Red Triangle Refer to product information or Medusa IV guide for instructions on administration. Must be diluted and buffered prior to administration by IV infusion. Not suitable for IV bolus. 

unlicensed Use in children is off label.

10.01.01 Diclofenac with misoprostol Arthrotec®

Diclofenac not a first line NSAID.

Consider using a preferred NSAID (e.g. ibuprofen or naproxen) or celecoxib ± gastroprotection (e.g. PPI) as alternative

05.03.01 Didanosine 
13.11 Didecyldimonium chloride 1% wash Stellisep med

From NHS logistics

10.03.02 Diethylamine salicylate Algesal®

Self Care Self Care Medicine

08.03.01 Diethylstilbestrol 
13.04 Diflucortolone valerate 0.3% Nerisone Forte®
02.01.01 Digoxin 
02.01.01 Digoxin 
02.01.01 Digoxin specific antibody fragments Digifab®
18 Digoxin specific antibody fragments Digifab®
04.07.02 Dihydrocodeine 
02.06.02 Diltiazem 60mg 

Suitable for generic prescribing.

02.06.02 Diltiazem Hydrochloride Zemtard XL®

For angina if not on beta-blocker

Once daily preparation

Prescribe by brand name

02.06.02 Diltiazem Hydrochloride Viazem XL®

For angina if not on beta-blocker.

Once daily preparation.

Prescribe by brand name

18 Dimercaprol 
08.02.04 Dimethyl fumarate Tecfidera®
13.05.02 Dimethyl fumarate Skilarence®
07.04.04 Dimethyl sulfoxide 50% solution 

unlicensed unlicensed

Restricted Item Urology specialist only

13.10.04 Dimeticone 

note For head lice.

Self Care Self Care Medicine. Can be purchased OTC (e.g. Hedrin®).

07.01.01 Dinoprostone 

Pessary off-label use at UHS for outpatient induction of labour (see staffnet for guideline)

07.01.01.01 Dinoprostone 

Off-label use

08.01.05 Dinutuximab beta Qarziba®
13.05.03 Diphenylcyclopropenone in acetone 0.00001-6.0% w/v 

Restricted Item Dermatology only

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

Red Triangle Topical immunotherapy - highly sensitising. To be applied only by trained professionals. Wear gloves when handling.

13.07 Diphenylcyclopropenone in acetone 0.00001-6.0% w/v 

Restricted Item Dermatology only

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

Red Triangle Topical immunotherapy - highly sensitising. To be applied only by trained professionals. Wear gloves when handling.

14.04 Diphtheria, tetanus, acellular pertussis, IPV, HiB and hepatitis B Infanrix Hexa®
13.02.01 Diprobase® 
02.09 Dipyridamole 

Only if opening capsules is inappropriate

Liquid is sugar free

02.09 Dipyridamole 
11.99.99.99 Disodium edetate 0.37% eye drops 

unlicensed Unlicensed

06.06.02 Disodium pamidronate 
02.03.02 Disopyramide 
02.03.02 Disopyramide 
04.10.01 Disulfiram Antabuse®
13.05.02 Dithranol 

note For short term use

13.05.02 Dithranol in Lassar's Paste 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

02.07.01 Dobutamine 
08.01.05 Docetaxel 
01.06.02 Docusate Sodium 
05.03.01 Dolutegravir 
05.03.01 Dolutegravir sodium/lamivudine Dovato®

Restricted Item For specialist use only.

For the treatment of Human Immunodeficiency Virus (HIV-1) infected adults and adolescents over 12 years of age

05.03.01 Dolutegravir sodium/rilpivirine hydrochloride Juluca®

For the treatment of Human Immunodeficiency Virus (HIV-1) infected adults

04.06 Domperidone 

unlicensed unlicensed suppositories. Also used off-label for stimulation of lactation (contra-indicated in patients with known cardiac problems).

Short-term use only. No longer indicated as a motility stimulant.

04.11 Donepezil 

Orodispersible  tablets only for patients unable to swallow tablets

02.07.01 Dopamine 
03.07 Dornase Alfa 
11.06 Dorzolamide 
11.06 Dorzolamide preservative-free Eydelto®

Restricted Item In primary care as a more cost effective alternative to unit dose eye drops. Only for patients allergic/intolerant of preservatives, or high risk of developing allergy

11.06 Dorzolamide with timolol 

Restricted Item Unit dose drops only for patients allergic/intolerant of preservatives, or high risk of developing allergy

11.06 Dorzolamide with timolol preservative-free Eylamdo®, Cosopt iMulti®

Restricted Item In primary care as a more cost effective alternative to unit dose eye drops. Only for patients allergic/intolerant of preservatives, or high risk of developing allergy.

13.02.01 Doublebase® 

note Consider Isomol or Zerodouble as more cost effective alternatives.

May also be applied before washing, showering or bathing.

15.01.07 Doxapram Dopram®
02.05.04 Doxazosin 

Not XL (prolonged-release) tablet

07.04.01 Doxazosin 

Modified release tablets are non-formulary

08.01.02 Doxorubicin 

Liposomal is a HCD high cost drug

05.01.03 Doxycycline 

Dispersible tablets only if cannot swallow caps

05.01.03 Doxycycline 

unlicensed unlicensed

05.04.01 Doxycycline 
13.06.02 Doxycycline  

noteDispersible tabs only if patient cannot swallow caps.

Second-line to oxytetracycline/lymecycline for acne.

13.02.02 Drapolene® 
02.03.02 Dronedarone Multaq®
06.01.02.03 Dulaglutide Trulicity®

Once weekly formulation.

04.07.03 Duloxetine 

For neuropathic pain in accordance with NICE Guidelines

13.08.01 Dundee reflectant sunscreens 

Restricted Item Dermatology recommendation only

note From British Association Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.05.03 Dupilumab Dupixent®) (dermatology

Restricted Item Specialist use only for atopic dermatitis in eligible adult patients (see NICE TA534) - commissioned by CCGs.

Commissioned by NHS England for adolescent patients 12 to 18 years if the patient is seen within a specialist treatment centre (e.g. specialised paediatric dermatology and/or paediatric allergy) and meets the criteria set out in NICE TA534. Patients must be registered via Blueteq.

 

Red Triangle Currently non-formulary for severe asthma (awaiting NICE TA guidance - due May 2020)

08.01.05 Durvalumab Imfinzi®
09.01.03 Eculizumab 
02.08.02 Edoxaban Lixiana®

note Due to cost effectiveness this is the first choice DOAC locally for prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF). See DPC Anticoagulant Decision Aid.

Note: other DOACs may be used if considered more clinically appropriate.

05.03.01 Efavirenz 
05.03.01 Efavirenz/emtricitabine/tenofovir disoproxil fumarate  Atripla®
13.09 Eflornithine Vaniqa®

note Only when other available options are inappropriate or ineffective

09.01 Efmoroctocog alfa Elocta®
05.03.03.02 Elbasvir with grazoprevir Zepatier®
A2.01.01.02 Elemental 028 ® Extra 

Not held in stock but available to order through pharmacy

100g powder - unflavoured

250ml liquid - Grapefruit/Orange/Pineapple/Summer fruit

09.01.04 Eltrombopag Revolade®
01.04.02 Eluxadoline Truberzi®
05.03.01 Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate  Genvoya®

Restricted Item Specialist only, in line with NHSE Clinical Commissioning Policies 16043/P and F/03/P/b

05.03.01 Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate Stribild®

Restricted Item Specialist only, in line with NHSE Clinical Commissioning Policy F03/P/b

09.01.03 Emicizumab 
06.01.02.03 Empagliflozin 
05.03.01 Emtricitabine 
05.03.01 Emtricitabine/rilpivirine/tenofovir alafenamide fumarate Odefsey®

Restricted Item Specialist only, in line with NHSE Clinical commissioning policy 16043/P

05.03.01 Emtricitabine/tenofovir alafenamide fumarate Descovy®

Restricted Item Specialist only, in line with NHSE Clinical Commissioning Policy 16043/P

05.03.01 Emtricitabine/tenofovir disoproxil fumarate 

Restricted Item When Zidovudine/lamivudine is unsuitable

13.02.01 Emulsiderm® Emollient 

note Not a first line bath additive. Contains antimicrobial.

13.02.01.01 Emulsiderm® Emollient 

note Note: contains an antimicrobial. Not recommended for long-term use.

13.02.01.01 Emulsiderm® Emollient 

note Note: contains an antimicrobial. Not recommended for long-term use.

13.02.01 Emulsifying Ointment 
02.05.05.01 Enalapril  
08.01.05 Encorafenib Braftovi®
A2.04.01.02 Energivit ®  

Ordered via main stores

02.08.01 Enoxaparin/enoxaparin biosimilar 

Amber Amber for extended thromboprophylaxis
Amber Amber in pregnancy
Green Green for other recognised indications

Prescribe by brand name.

Ensure patients are counselled on use of the relevant device.

Arovi, Enoxaparin Becat and Inhixa brands are black triangle

 

04.09.01 Entacapone 

Can be used with levodopa preparations to reduce “off-time” in later Parkinson’s disease

05.03.03.01 Entecavir 
08.03.04.02 Enzalutamide Xtandi®

Note: not recommended for treating high-risk hormone-relapsed non-metastatic prostate cancer in adults, in accordance with NICE TA580

13.11.06 Eosin 2% 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

02.07.02 Ephedrine 
03.01.01.02 Ephedrine  

Also off-label for diabetic neuropathy

12.02.02 Ephedrine 
13.02.01 Epimax Paraffin-free 

Restricted Item For use only in patients intolerant to paraffin-containing products.

Note: MHRA safety warnings re: fire risks also apply to paraffin-free emollients.

13.02.01 Epimax®/ Diprobase ® 

note Also suitable for use as soap substitute.

Epimax first line choice as more cost effective.

 

13.02.01 Epimax®/ Epaderm®/ Hydromol® 

note Epimax ointment 1st line as more cost effective option and same active ingredients as Epaderm.

For use as emollient/bath additive or as barrier cream.

08.01.02 Epirubicin 
02.02.03 Eplerenone 

If hormonal side effects on spironolactone

To reduce the risk of CV mortality and morbidity in selected patients after recent MI or with CHF

09.01.03 Epoetin alfa Eprex®
09.01.03 Epoetin beta NeoRecormon®

also for paediatric renal patients

02.08.01 Epoprostenol Flolan®
02.09 Eptifibatide Integrilin®
09.06.04 Ergocalciferol Vitamin D2
07.01.01 Ergometrine Maleate 
07.01.01 Ergometrine Maleate and Oxytocin Syntometrine®
08.01.05 Eribulin 
08.01.05 Erlotinib 
05.01.02.02 Ertapenem 
06.01.02.03 Ertugliflozin 
05.01.05 Erythromycin 
13.06.02 Erythromycin 

note Not a first-line option in acne.

13.06.01 Erythromycin 2% with isotretinoin 0.05% 
04.03.03 Escitalopram 

Third line on specialist advice

Oral drops (Cipralex®) are Non Formulary

04.08.01 Eslicarbazepine Zebinix®
02.04 Esmolol 

Restricted Item Critical care only

01.03.05 Esomeprazole 

Restricted Item  Child Health only

01.03.05 Esomeprazole  Only for Grade III to IV oesophagitis unresponsive to high dose omeprazole.
06.04.01.01 Estradiol Evorel®
07.02.01 Estradiol  
07.02.01 Estriol Ovestin®
02.11 Etamsylate 

Restricted Item Countess Mountbatten House use only

unlicensed unlicensed

10.01.03 Etanercept/etanercept biosimilar Enbrel®, Benepali®, Erelzi®) (Rheumatology

note Specify brand

Erelzi is black triangle

13.05.03 Etanercept/etanercept biosimilar Enbrel®, Benepali®, Erelzi®) (dermatology

note Specify brand.

Benepali and Erelzi are black triangle

09.05.01.02 Etelcalcetide Parsabiv®
05.01.09 Ethambutol  
18 Ethanol (alcohol) injection 
02.13 Ethanolamine Oleate 
06.04.01.01 Ethinylestradiol 
08.03.01 Ethinylestradiol 
07.03.01 Ethinylestradiol / levonorgestrel phased pill TriRegol®

For existing patients only. No longer routinely recommended

07.03.01 Ethinylestradiol 20 mcg / norethisterone 1mg Loestrin 20®
07.03.01 Ethinylestradiol 20mcg / desogestrel 150mcg Gedarel 20/150®
07.03.01 Ethinylestradiol 30 mcg / drospirenone 3 mg Yasmin®
07.03.01 Ethinylestradiol 30mcg / desogestrel 150mcg Gedarel 30/150®
07.03.01 Ethinylestradiol 30mcg / gestodene 75 mcg Millinette®
07.03.01 Ethinylestradiol 30mcg / levonorgestrel 150mcg Rigevidon®, Microgynon 30®

Rigevidon brand is Blue

Microgynon brand is Green

07.03.01 Ethinylestradiol 35 mcg / noresthisterone 1mg Norimin®
07.03.01 Ethinylestradiol 35 mcg / noresthisterone 500mcg Ovysmen®
07.03.01 Ethinylestradiol 35 microgram/Norgestimate 250mg  Cilest®
07.03.01 Ethinylestradiol with etonogestrel NuvaRing®

Low strength.

04.08.01 Ethosuximide 
15.02 Ethyl Chloride Cryogesic®
15.01.01 Etomidate Hypnomidate®
07.03.02.02 Etonorgestrel Nexplanon®

Only to be inserted and removed by trained professionals

08.01.04 Etoposide 
10.01.01 Etoricoxib Arcoxia®
05.03.01 Etravirine 
08.01.05 Everolimus Votubia®

For use as per commissioning criteria set by NHS England

08.01.05 Everolimus Afinitor®
02.11 Evicel® kit 

Restricted Item Specialist use only

02.12 Evolocumab Repatha®
13.02.01 ExCetra® 

note Similar to Cetraben cream

08.03.04.01 Exemestane 
06.01.02.03 Exenatide Byetta®
06.01.02.03 Exenatide prolonged release Bydureon®

Once weekly formulation.

02.12 Ezetimibe Ezetrol®

Mainly reserved as an adjunct to statins for patients with primary hypercholesterolaemia.

01.03.01 Famotidine 

Restricted Item For use only as an alternative H2-antagonist when ranitidine is not available, and a proton pump inhibitor is not suitable.

10.01.04 Febuxostat Adenuric®
02.12 Fenofibrate 

First choice fibrate.

Consider only when a statin or other treatments are contraindicated or not tolerated.

04.07.02 Fentanyl Actiq®

Restricted Item  Adult Acute Pain Team only

For painful procedures

Fentanyl lozenge with oromucosal applicator

04.07.02 Fentanyl 

Not first line opioid choice

15.01.04.03 Fentanyl 
04.07.02 Fentanyl Nasal Spray PecFent®

Restricted Item For cancer care/palliative care specialist initiation only.

Prescribe by brand name.

For the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Only for patients unable to tolerate, or unsuitable for treatment with, oral formulations of other opioids (e.g. morphine, oxycodone).

 

04.07.02 Fentanyl sublingual tablets Abstral®

Restricted Item For cancer care/palliative care specialist initiation only.

Prescribe by brand name.

For the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. Only for patients unable to tolerate, or unsuitable for treatment with, oral formulations of other opioids (e.g. morphine, oxycodone).

09.01.01.02 Ferric Carboxymaltose Ferinject®

Drug of choice in antenatal and postnatal women. See local Trust Guideline.

09.01.01.01 Ferric maltol Feraccru®

Restricted Item Gastroenterology specialist initiation only.

Only for patients with IBD unable to tolerate other iron preparations

09.01.01.01 Ferrous Fumarate 
09.01.01.01 Ferrous fumarate and Folic Acid Pregaday®
09.01.01.01 Ferrous Sulphate 
03.04.01 Fexofenadine 
20 Fibrin Sealant Tisseel®
05.01.07 Fidaxomicin 

Restricted Item Microbiology recommendation only for first episode of severe Clostridium difficile when concurrent antibiotics cannot be stopped and for second episodes of Clostridium difficile.

09.01.06 Filgrastim 

Specify brand

06.04.02 Finasteride 

for men with a significantly enlarged prostate

08.02.04 Fingolimod 
02.03.02 Flecainide 

Restricted Item Specialist use only.

02.03.02 Flecainide 

Restricted Item Specialist use only

unlicensed Unlicensed liquid special 25mg in 5mL restricted to paediatrics unable to swallow until solid dosage forms are suitable.

13.10.05 Flexible collodion BP 
05.01.01.02 Flucloxacillin 
05.02.01 Fluconazole 
05.02.01 Fluconazole 
05.02.05 Flucytosine 
08.01.03 Fludarabine Phosphate 
06.03.01 Fludrocortisone 
13.04 Fludroxycortide  

note Prescribe as generic - Haelan brand discontinued Sept 2016

15.01.07 Flumazenil 
12.01.01 Flumetasone 0.02% with clioquinol 1% Locorten Vioform ®
11.04.01 Fluocinolone acetonide Iluvien®
11.08.02 Fluorescein 

Minims®. Preservative-free.

11.04.01 Fluorometholone  FML®
08.01.03 Fluorouracil 
13.08.01 Fluorouracil 5% Efudix®

Treatment of choice for actinic keratoses - recommended by Community Dermatology services (see guidance here).

13.08.01 Fluorouracil and salicylic acid  Actikerall®
04.03.03 Fluoxetine 

note consider oral solution as a more cost effective alternative to 10mg capsules

04.02.01 Flupentixol 
04.03.04 Flupentixol 
04.02.02 Flupentixol decanoate 

note For deep intramuscular injection

04.02.02 Fluphenazine decanoate Modecate®

note For deep intramuscular injection

 Product has been discontinued in UK, supplies expire in Aug 2020

08.03.04.02 Flutamide 
03.02 Fluticasone /umeclidinium / vilanterol Trelegy Ellipta®

note Prescribing by brand name recommended

12.02.01 Fluticasone furoate Avamys®

Second or third line for nasal allergy for patients who do not respond to beclometasone dipropionate, or who need a different device.

03.02 Fluticasone furoate and vilanterol Relvar Ellipta®

note Prescribing by brand name recommended

Higher strength formulation (184/22) licensed only for asthma, not for COPD

03.02 Fluticasone propionate 

note Prescribing by brand name recommended

12.02.01 Fluticasone propionate Flixonase Nasule Drops®

For treatment of symptoms of severe chronic rhinosinusitis with nasal polyps as second line option if control with glucocorticoid nasal sprays is insufficient.

unlicensed unlicensed in children under 16 years old.

13.04 Fluticasone propionate 0.005% Cutivate®
13.04 Fluticasone propionate 0.05% Cutivate®
03.02 Fluticasone propionate and formoterol Flutiform®

note Prescribing by brand name recommended

Licensed for asthma only, not for COPD

09.01.02 Folic Acid 
06.05.01 Follitropin Alfa 
18 Fomepizole 

unlicensed unlicensed

02.08.01 Fondaparinux Arixtra®

  • for thromboprophylaxis when history of heparin-induced thrombocytopenia only when danaparoid is unobtainable
  • as an adjunct to thrombolysis with tenecteplase in STEMI
  • for NSTEMI
  • for superficial thrombophlebitis
13.07 Formaldehyde 0.75% Veracur®
03.01.01.01 Formoterol fumarate 

note Prescribe by brand name

e.g. Atimos Modulite; Formoterol Easyhaler; Oxis Turbohaler

A2.02.02.03 Forticreme ® Complete 

4 x 125g in stock in pharmacy.

Vanilla/chocolate/forest fruit

A2.02.01.02 Fortijuce ®  

24 x 200ml stocked in pharmacy

Apple/Lemon/Strawberry

Orange/Forest Fruit/Blackcurrant - Not held in stock but available to order through pharmacy

A2.02.02.02 Fortimel ® Regular 

Not held in stock but available to order through pharmacy

200ml - Forest Fruit/Vanilla/Chocolate/Strawberry

A2.01.03.03 Fortini® 

24 x 200ml stocked in pharmacy.

Strawberry/Vanilla

For paediatric wards only

A2.02.02.03 Fortini® compact multifibre 

Not held in stock but available to order through pharmacy

4x125ml - Strawberry/Neutral

A2.03 Fortini® creamy fruit multifibre 

Not held in stock but available to order through pharmacy

4 x 100g - Berry, Summer fruit

Paediatric wards only

A2.02.01.02 Fortini® smoothie multifibre 

200ml stocked in pharmacy.

Summer fruit/berry fruit

Paediatric wards only

A2.02.02.03 Fortisip ® Compact Fibre 

Not held in stock but available to order through pharmacy.

125ml - Vanilla/Strawberry/Mocha

A2.02.02.03 Fortisip ® Extra 

Not held in stock but available to order through pharmacy

200ml - Chocolate/Forest Fruit/Vanilla/Strawberry

A2.02.02.01 Fortisip ® Bottle 

Chocolate, strawberry, vanilla, banana stocked in pharmacy

A2.02.02.01 Fortisip ® Multi Fibre 

Not held in stock but available to order through pharmacy

200ml - Chocolate/Orange/Vanilla

A2.02.02.03 Fortisip® Compact 

24 x 125ml in stock in pharmacy. Banana, vanilla, strawberry, mocha

A2.02.02.03 Fortisip® Compact Protein 

Not held in stock but available to order through pharmacy

Vanilla/Strawberry/banana/Mocha

A2.02.02.01 Fortisip® Yoghurt style 

Not held in stock but available to order through pharmacy

24 x 200ml - Vanilla/Lemon/Raspberry

05.03.01 Fosamprenavir 
05.03.02.02 Foscarnet Sodium 
05.01.07 Fosfomycin 

Prescribe as Monuril sachets in primary care

04.07.04.02 Fremanezumab Ajovy®

Restricted Item Note: not supported for use in episodic migraine (see NICE TA631).

A2.02.02.01 Fresubin thickened stage 2® 

4 x 200ml stocked in pharmacy.

Vanilla/Wild strawberry

13.05.02 Fumaric acid esters Fumaderm®

Restricted Item Dermatology only; for psoriasis

unlicensed Unlicensed

02.02.02 Furosemide 
11.03.01 Fusidic acid 
13.10.01.02 Fusidic acid 2% 
A2.07 GA1 Anamix ® Infant 

Ordered via main stores

04.07.03 Gabapentin 

For neuropathic pain in accordance with NICE Guidelines

First line if pain is lancinating in nature (‘electric shocks’)

04.08.01 Gabapentin 
04.11 Galantamine 

Liquid only for patients unable to swallow tablets

05.03.02.02 Ganciclovir 
11.03.03 Ganciclovir  

note for use when aciclovir is not available

01.06.07 Gastrografin 

Restricted Item Specialist use only

01.01.02 Gaviscon Advance 
08.01.05 Gefitinib 
09.02.02.02 Gelofusine  
08.01.03 Gemcitabine 
08.01.05 Gemtuzumab ozogamicin Mylotarg®
05.01.04 Gentamicin 
11.03.01 Gentamicin 
12.01.01 Gentamicin 0.3% 
12.01.01 Gentamicin 0.3% with hydrocortisone acetate 1% Gentisone® HC
12.03.05 Glandosane ® 
08.02.04 Glatiramer acetate 

Restricted Item Specialist use only for multiple sclerosis

05.03.03.02 Glecaprevir with pibrentasvir Maviret®
06.01.02.01 Gliclazide 
06.01.02.01 Glipizide 
06.01.04 Glucagon  injection
06.01.06 Glucose Diastix®
06.01.04 Glucose 40%  
06.01.04 Glucose 50% injection 
09.02.02.01 Glucose Intravenous 

Glucose 5% intravenous infusion

Glucose 10% intravenous infusion

Glucose 20% intravenous infusion

Glucose 50% intravenous infusion

12.03.04 Glycerin and lemon mouth swabs 
01.06.02 Glycerol 
11.99.99.99 Glycerol (glycerin) BP 
02.06.01 Glyceryl Trinitrate 
02.06.01 Glyceryl Trinitrate 
01.07.04 Glyceryl trinitrate 0.4% 
02.06.01 Glyceryl Trinitrate 5mg/ml 
07.04.04 Glycine 
03.01.02 Glycopyrronium Seebri Breezhaler®

note Prescribing by brand name recommended

Licensed for COPD only, not for asthma

15.01.03 Glycopyrronium 
13.12 Glycopyrronium (glycopyrrolate) 0.05% 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

Restricted Item Dermatology only - for use in iontophoresis, second-line to tap water. To be initiated in secondary care.

13.12 Glycopyrronium (glycopyrrolate) 2% Formula A

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

Restricted Item Dermatology only.

03.01.04 Glycopyrronium and indacaterol Ultibro Breezhaler®

note Prescribing by brand name recommended

15.01.06 Glycopyrronium and Neostigmine 
01.02 Glycopyrronium Bromide 1mg/5ml 

Restricted Item For severe sialorrhoea in children and adolescents with chronic neurological disorders.

Note: not licensed in adults.

 

01.05.03 Golimumab Simponi®) (Gastroenterology

unlicensed unlicensed use in Crohns disease (off licence indication).

10.01.03 Golimumab Simponi®) (Rheumatology
06.05.01 Gonadorelin (LHRH)
06.07.02 Goserelin  

Restricted Item Red formulary status for fertility treatment. Specialist prescribing only.

08.03.04.02 Goserelin 
04.06 Granisetron 

After ondansetron has failed in children receiving chemotherapy and patients with gastrointestinal failure

04.06 Granisetron Sancuso®

Restricted Item Specialist use only as per licensed indications

03.04.02 Grass and Tree Pollen Extract Pollinex®

Restricted Item Specialist allergy clinics only

03.04.02 Grass pollen allergen extract Grazax®

Restricted Item Specialist allergy clinics only.

02.05.03 Guanethidine Monosulphate Ismelin®
04.04 Guanfacine Intuniv®

Specialist initiation only

As per DPC Shared Care Guidelines (pending publication)

13.05.03 Guselkumab 
09.08.02 Haem Arginate 
14.04 Haemophilus influenzae type B and Meningococcal group C conjugate vaccine Menitorix®
03.01.05 Haleraid ® 
04.02.01 Haloperidol 
04.09.03 Haloperidol 
04.02.02 Haloperidol decanoate HALDOL® Decanoate

note For deep intramuscular injection

A2.07 HCU Anamix ® Infant 

Ordered via main stores

09.02.02 Heparin 
02.08.01 Heparin calcium 
02.08.01 Heparin sodium 
02.08.01 Heparin sodium 

Restricted Item Restricted use in primary care. GPs to prescribe only for children for administration by specialist paediatric community nurses.

14.04 Hepatitis A vaccine 
14.04 Hepatitis A vaccine with typhoid vaccine Hepatyrix®
14.05.02 Hepatitis B immunoglobulin HBIG

Microbiology request only

14.04 Hepatitis B vaccine 
07.04.04 Hexaminolevulinate 

Restricted Item Urology specialist only

09.02.01.02 High sodium powders 

Restricted Item Nutrition team only. Patients may prepare themselves following advice and recipe from specialist/nutrition team.

unlicensed Unlicensed

09.02.02.01 Histidine, tryptophan, ketoglutarate Custodiol® HTK

Restricted Item Restricted - for specialist cardiac surgery use only. For administration into renal arteries as renal protection during open thoracoabdominal aortic aneurysm repair surgery.

unlicensed use for this indication is off label

Classed as a Medical device - CE Marked

09.02.02.02 Human albumin  

Human albumin 4.5% solution

Human albumin 20% solution

06.05.01 Human Menopausal Gonadotrophins Menopur/Merional®
14.04 Human papilloma virus vaccine Gardasil®
07.05 Hyaluronic acid  

Restricted Item For localised use in the uterus only, for prevention of adhesions. Use products registered as medical devices (i.e. CE marked) or medicines only, e.g. Hyalobarrier®; Hyaregen®; Materegen®.

02.05.01 Hydralazine 
02.05.01 Hydralazine 
01.05.02 Hydrocortisone 
06.03.01 Hydrocortisone 
06.03.01 Hydrocortisone Alkindi®

Restricted Item Restricted for use only when standard tablets are not suitable or practical, e.g. infants/young children on doses <5mg.

UHS will only routinely stock lower strengths, i.e. 0.5mg, 1mg and 2mg.

Patients on doses ≥5mg should be switched to standard tablets, which can be divided using a tablet cutter. 

Unlicensed in patients ≥18 years. Discuss options for adult patients unable to swallow tablets with pharmacist.

13.04 Hydrocortisone 0.5% & 1% 
13.04 Hydrocortisone 1% with clotrimazole 1% Canesten HC®

note For short-term use

13.04 Hydrocortisone 1% with fusidic acid 2% Fucidin H®

note For short-term use

13.04 Hydrocortisone 1% with miconazole 2% Daktacort®

note For short-term use

12.03.01 Hydrocortisone 2.5mg 

Self Care Available OTC

10.01.02.02 Hydrocortisone acetate Hydrocortistab®
13.04 Hydrocortisone butyrate 0.1% Locoid®
12.01.01 Hydrocortisone/neomycin/polymixin B Otosporin®
13.11.06 Hydrogen peroxide 10 Vol (3%) 
13.11.06 Hydrogen peroxide BP 

10 Vol (3%)

20 Vol (6%)

A2.03.01 Hydrolysed Nutriprem (Cow and Gate®) 

Ordered through main stores

13.02.01.01 Hydromol® 

note Fragrance-free.

13.08.02 Hydroquinone 5%, hydrocortisone 1% and tretinoin 0.1% Pigmanorm®

unlicensed Unlicensed

Restricted Item Dermatology only.

09.01.02 Hydroxocobalamin Vitamin B12

IM injection preferred over oral administration for non-dietary vitamin B12 deficiency

18 Hydroxocobalamin Cyanokit®
18 Hydroxocobalamin 
08.01.05 Hydroxycarbamide 
10.01.03 Hydroxychloroquine 

Restricted Item Supported only for indications detailed in Shared Care Guidelines.

Not for use in Covid-19 treatment/prevention outside of clinical trials (see links below). Seek further advice from infection control specialist/pharmacy team.

13.05.03 Hydroxychloroquine dermatology

Restricted Item Supported only for use in indications detailed in Shared Care guidelines.

Not for use in Covid-19 treatment/prevention outside of clinical trials (see links below). Seek further advice from infection control specialist/pharmacy team.

11.99.99.99 Hydroxypropylmethylcellulose in balanced salt solution inj  

unlicensed Unlicensed

03.04.01 Hydroxyzine 

Restricted Item Dermatology only

11.08.01 Hylo Night ® 

 note For use in line with DPC dry eye guidelines (link below)

Preservative-free

Contains retinol palmitate (vitamin A), liquid paraffin and wool fat.

Previously known as VitA-POS eye ointment.

01.02 Hyoscine Butylbromide 
04.06 Hyoscine hydrobromide 

Tablets/patch may also be used off-label for hypersalivation

15.01.03 Hyoscine Hydrobromide 
11.08.01 Hypromellose  

note To be used in line with DPC dry eye guidelines (link below)

11.08.01 Hypromellose preservative-free  multi use 10ml bottle

note To be used in line with DPC dry eye guidelines (link below).

Restricted Item Only for patients allergic/intolerant of preservatives or high risk of developing allergy.

06.06.02 Ibandronic acid 

For prevention of skeletal events in patients with breast cancer and bone metastases.

unlicensed 'Off label' use for post-menopausal women with breast cancer who are assessed by a specialist to be at sufficient risk of breast cancer recurrence. Refer to DPC shared care guidance: Adjuvant Bisphosphonates for Early Breast Cancer Feb 2018

06.06.02 Ibandronic acid 

Restricted Item Specialist use only for osteoporosis.

For patients unable to tolerate oral medication

06.06.02 Ibandronic acid 

For osteoporosis

08.01.05 Ibrutinib Imbruvica®
07.01.01.01 Ibuprofen injection
10.01.01 Ibuprofen 

A first line NSAID, except for gout

10.01.01 Ibuprofen 
10.03.02 Ibuprofen 5% 

Self Care Self Care Medicine

03.04.03 Icatibant Firazyr®

Restricted Item For use as per commissioning criteria set by NHS England

13.05.01 Ichthammol 1% & zinc oxide 15% 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.05.01 Ichthammol glycerin BPC 
08.01.02 Idarubicin 
02.08.03 Idarucizumab Praxbind®

  • Restricted Item On  Consultant Haematologist advice only (refer to UHS guideline).
  • When rapid reversal of dabigatran is required for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
11.08 Idebenone Raxone®

Restricted Item In line with NHS England commissioning criteria

08.01.05 Idelalisib 
08.01.01 Ifosfamide 
02.05.01 Iloprost 100micrograms/ml 

Refer to UHS Iloprost Intravenous Infusion Guidelines

08.01.05 Imatinib 
05.01.02.02 Imipenem with Cilastatin 
04.03.01 Imipramine 

note May be considered as a potential second line alternative when amitriptyline is not suitable/not tolerated

13.07 Imiquimod 5% 

For anogenital warts.

Restricted Item Not supported for treatment of actinic keratoses.

03.01.01.01 Indacaterol Onbrez Breezhaler®

note Prescribe by brand name.

Licensed only for COPD, not for asthma

02.02.01 Indapamide 
11.08.02 Indocyanine green 
07.01.01.01 Indometacin 

unlicensed Unlicensed

10.01.01 Indometacin 

Not a first line NSAID

unlicensed Liquid is unlicensed

13.11.01 Industrial Methylated Spirit 70%/95% IMS
01.01.02 Infant Gaviscon ® 

Children only

A2.01.03.02 Infatrini ® 

Not held in stock but available to order through pharmacy

100ml/200ml/500ml - Unflavoured

A2.03.01 Infatrini Peptisorb® 

200ml stocked in pharmacy

01.05.03 Infliximab Remsima®, Inflectra®, Flixabi®) (Gastroenterology

note Specify brand.

01.05.03 Infliximab Remicade®)(Gastroenterology

note Specify brand

10.01.03 Infliximab/infliximab biosimilar rheumatology

note Specify brand (e.g. Remicade®, Remsima®, Inflectra®, Flixabi®, Zessly®)

 

13.05.03 Infliximab/infliximab biosimilar dermatology

note Specify brand (e.g. Remicade®, Remsima®, Inflectra®, Flixabi®, Zessly®)

14.04 Influenza vaccine  
09.08.01 Inotersen Tegsedi®
08.01.05 Inotuzumab ozogamicin Besponsa®
06.01.01.01 Insulin Humulin® S
06.01.01.01 Insulin Actrapid®
06.01.01.01 Insulin 500 units in 1mL Humulin R®

unlicensed Unlicensed. 

Restricted Item Monitoring and prescribing by specialists only.

06.01.01.01 Insulin Aspart  NovoRapid®
06.01.01.01 Insulin aspart fast-acting Fiasp®

Restricted Item Specialist recommendation, only for type 1 diabetes

06.01.01.02 Insulin degludec Tresiba®

Restricted Item Initiated and stabilised by a specialist for difficult to manage patients with type 1 diabetes

06.01.01.02 Insulin degludec Tresiba®

As per DPC Jun 19

06.01.01.02 Insulin degludec and liraglutide Xultophy®
06.01.01.02 Insulin detemir Levemir®
06.01.01.02 Insulin glargine Lantus®

note Specify brand.

Biosimilar preferred for new patients.

06.01.01.02 Insulin glargine Toujeo®

Restricted Item Specialist initiation

06.01.01.02 Insulin glargine biosimilar Abasaglar®; Semglee®

note Specify brand. 

06.01.01.01 Insulin lispro  Humalog®

Restricted Item Specialist initiation

06.01.01.01 Insulin lispro  Humalog®
05.03.03 Interferon alfa 
08.02.04 Interferon Alfa 
11.08.02 Interferon alfa 2a  

unlicensed Unlicensed

Restricted Item For specialist use only

08.02.04 Interferon Beta 

For use as per specialist commissioning criteria

 

Restricted Item Not for use in Covid-19 treatment outside of clinical trials. Seek further advice from infection control specialist/pharmacy team.

07.03.02.03 Intra-uterine Progestogen Only System Mirena®

Contains 52mg levonorgestrel

07.03.02.03 Intra-uterine Progestogen Only System Kyleena®

For contraception only

Contains 19.5mg levonorgestrel 

07.03.02.03 Intra-uterine Progestogen Only System Levosert®

Alternative to Mirena (for contraception and heavy menstrual bleeding only - not licensed for endometrial protection with HRT)

Note: different insertion device/technique vs Mirena

Contains 52mg levonorgestrel

07.03.02.03 Intra-uterine Progestogen Only System  Kyleena®

Off-label use in obstetrics for heavy menstrual bleeding where Mirina or Levosert devices are too large.

Contains 19.5mg levonorgestrel 

13.11.04 Iodine alcoholic solution BP 
06.02.02 Iodine and Iodide 
13.11.04 Iodine aqueous solution BP 
08.01.05 Ipilimumab 
03.01.02 Ipratropium 
08.01.05 Irinotecan 
09.01.01.02 Iron Isomaltoside Monofer®
09.01.01.02 Iron Sucrose Venofer®
05.02.01 Isavuconazole Cresemba®
15.01.02 Isoflurane 
13.02.01 Isomol®/Zerodouble® 

note Also suitable for use as a soap substitute.

Similar to Doublebase gel.

05.01.09 Isoniazid 

unlicensed Liquid is unlicensed

06.01.01.02 Isophane Insulin Insulatard®
06.01.01.02 Isophane Insulin Humulin® I
02.07.01 Isoprenaline 

unlicensed unlicensed

13.11.01 Isopropyl alcohol 70% 
02.06.01 Isosorbide Mononitrate Isotard XL®
02.06.01 Isosorbide Mononitrate 
13.06.02 Isotretinoin 

Restricted Item Hospital only

01.06.01 Ispaghula Husk 
05.02.01 Itraconazole 
05.02.01 Itraconazole 
A2.07 IVA Anamix ® Infant 

Ordered via main stores

02.06.03 Ivabradine 

Third-line option for stable angina in accordance with NICE guidelines

02.06.03 Ivabradine 

For heart failure

03.07 Ivacaftor Kalydeco®

Routinely commissioned for patients age 6 and over with cystic fibrosis and G551D mutation

13.06.01 Ivermectin 

note First line option for papulopustular rosacea

13.10.04 Ivermectin 

Restricted Item  On microbiology advice only

unlicensed Unlicensed

08.01.05 Ixazomib Ninlaro®
10.01.03 Ixekizumab Taltz®
13.05.03 Ixekizumab Taltz®
15.01.01 Ketamine  
15.01.01 Ketamine  High strength 100mg/ml

unlicensed unlicensed 

Restricted Item Consultant anaesthetist use only. For acutely agitated/confused patients only

15.01.01 Ketamine S (preservative free) 

unlicensed unlicensed

Child Health only

A2.03.02 KetoCal ® 4:1 LQ 

Ordered via main stores

05.02.02 Ketoconazole 

Restricted Item Specialist use only

unlicensed unlicensed

MHRA - Oral ketoconazole: do not prescribe or use for fungal infections—risk of liver injury outweighs benefits

13.09 Ketoconazole 2% 
13.10.02 Ketoconazole 2% 
11.08.02 Ketorolac trometamol  Acular®

note Note: licensed for use up to 3 weeks post-operatively

15.01.04.02 Ketorolac trometamol 
01.06.05 Klean-Prep ® 
02.04 Labetalol 
02.04 Labetalol 
04.08.01 Lacosamide  Vimpat ®

For refractory partial epilepsy

Amber Tablet/liquid

Red Injection is red on formulary for those NBM

11.08.01 Lacri-lube®/Refresh Night Time®/Xailin Night® 

note To be used in line with DPC dry eye guidelines (link below)

Contains white soft paraffin, liquid paraffin, wool alcohols.

01.05 Lactobacillus 

Restricted Item For use on prescription under microbiology recommendation only

01.06.04 Lactulose 
03.04.02 Lais® 1,000 AU 

unlicensed Unlicensed

Restricted Item Specialist allergy clinics only. For use only when licensed alternatives are not suitable.

05.03.01 Lamivudine 
05.03.01 Lamivudine/abacavir/dolutegravir Triumeq®
04.08.01 Lamotrigine 

For primary generalised epilepsy (including absences and myoclonus), partial seizures, secondary generalised tonic-clonic seizures.

03.04.03 Lanadelumab 300mg  Takhzyro®
08.03.04.03 Lanreotide Somatuline Autogel®

For self administration

01.03.05 Lansoprazole 

Restricted Item Orodispersible tablets only for enteral tubes/patients with swallowing difficulties

09.08.01 L-Arginine  

unlicensed Unlicensed

08.01.05 Larotrectinib Vitrakvi®
11.06 Latanoprost 

note Generic prescribing recommended.

First line prostaglandin analogue.

Restricted Item Unit dose drops only for patients allergic/intolerant of preservatives, or high risk of developing allergy

11.06 Latanoprost with timolol 

note Generic prescribing recommended

First choice if a combination prostaglandin analogue/beta-blocker is required. 

Restricted Item Unit dose drops only for patients allergic/intolerant of preservatives, or high risk of developing allergy

13.02.02 LBF® Sterile Barrier Film 

Refer to Wound Formulary for further details

05.03.03.02 Ledipasvir with sofosbuvir Harvoni®
10.01.03 Leflunomide 
08.02.04 Lenalidomide  Revlimid®
08.01.05 Lenvatinib Kisplyx®; Lenvima®

note Lenvima for thyroid and hepatocellular carcinoma, Kisplyx for renal cell carcinoma

05.03.02.02 Letermovir Prevymis®
08.03.04.01 Letrozole 
06.07.02 Leuprorelin  

Restricted Item Red formulary status for fertility treatment (off label use). Specialist prescribing only.

08.03.04.02 Leuprorelin acetate 
04.08.01 Levetiracetam 
04.08.01 Levetiracetam 
11.06 Levobunolol 

Not a first line choice.

Restricted Item Unit dose drops only for patients allergic/intolerant of preservative, or high risk of developing allergy

15.02 Levobupivacaine Chirocaine®

High risk blocks only e.g. interscalene

Supply only to be made by Critical Care Pharmacists and use carefully monitored

15.02 Levobupivacaine 
09.08.01 Levocarnitine 
05.01.12 Levofloxacin Quinsair®

Restricted Item For use only in accordance with Aug 2018 NHS England Clinical Commissioning Policy for chronic Pseudomonas lung infection in cystic fibrosis (adults)

05.01.12 Levofloxacin 

Red Restricted Item Tablets/injection red for prophylaxis in multiple myeloma in line with UHS guidance (12 weeks treatment). Haematology only.
Green Restricted Item Tablets green for H pylori eradication in line with SCAN community antibiotic guidelines (note: not a first-line option)

11.03.01 Levofloxacin 0.5% 

note Following corneal graft surgery.

Unit dose drops if installation ≥ 6 times daily 

04.02.01 Levomepromazine 
04.06 Levomepromazine 

Palliative care

07.03.05 Levonorgestrel Levonelle® 1500
07.03.02.01 Levonorgestrel 30 microgram Norgeston®

For existing patients

02.01.02 Levosimendan 

unlicensed Unlicensed

Restricted Item Specialist use only in cardiac surgery patients for:

 - Life threatening post-operative low cardiac output syndrome where the patient is on maximum therapy (catecholamines) and phosphodiesterase inhibitors are contra-indicated/not tolerated.

 - Rarely pre-operatively for patients with very low cardiac output/ejection fraction (e.g. LVEF <25%).

 
06.02.01 Levothyroxine 
02.03.02 Lidocaine 
04.07.03 Lidocaine 

Restricted Item Restricted use.

Green for use in patients who have been treated in line with NICE CG173: Neuropathic pain, but are still experiencing pain associated with previous herpes zoster infection (post-herpetic neuralgia) (licensed indication).

Amber Initiation Amber for chronic neuropathic pain/focal neuralgia [unlicensed 'off label' use] in exceptional circumstances only (e.g. other treatment options have failed or cannot be used due to co-morbidities) in a co-operation arrangement with chronic pain or cancer care/palliative care specialist teams as per DPC Chronic Pain Prescribing Guidelines or Wessex Palliative Care Guidelines.

Red for use in rib fracture pain (see section 15.02)

15.02 Lidocaine  0.5%, 1% and 2%
15.02 Lidocaine 
15.02 Lidocaine 
15.02 Lidocaine  

Restricted Item unlicensed ‘Off label’ short term use (usual max 2 weeks) at UHS for management of acute pain associated with traumatic rib fractures (refer to protocol). All patients prescribed lidocaine plasters for rib fracture pain should be referred to the acute pain team.

Not suitable for primary care prescribing for this indication. For use in neuropathic pain refer to section 04.07.03.

15.02 Lidocaine 0.4% and glucose 5% 
02.03.02 Lidocaine 0.4% in glucose 5% 
15.02 Lidocaine 2.5% with Prilocaine 2.5% EMLA®
01.07.04 Lidocaine 5% 
15.02 Lidocaine and chlorhexidine  Instillagel®
15.02 Lidocaine with Adrenaline Lignospan®

Lidocaine 1% and adrenaline 1:80,000

Lidocaine 2% and adrenaline 1:80,000

Lidocaine 2% and adrenaline 1:200,000

15.02 Lidocaine, adrenaline and tetracaine LAT

unlicensed Unlicensed, ED for children only

01.06.07 Linaclotide Constella®

According to local algorithm

06.01.02.03 Linagliptin 

For patients with renal impairment

05.01.07 Linezolid 

Restricted Item Specialist use only. Only to be used in primary care under microbiologist recommendation.  Specialist to advise of any monitoring or potential drug interactions.

Liquid for patients unable to swallow tabs.

06.02.01 Liothyronine 
06.02.01 Liothyronine 

Red for use in thyroid cancer, radioiodine ablation, iodine scanning or stimulated thyroglobulin test.

Amber for thyroid deficiency. Specialist initiation. Ongoing prescribing in primary care in exceptional circumstances only when recommended by consultant NHS endocrinologist (refer to DPC Shared Care guidance).

08.01.05 Liposomal daunorubicin-cytarabine Vyxeos®
13.02.01 Liquid paraffin, white soft paraffin 50/50 

note Preservative and fragrance free.

Very greasy.

A2.04.01.02 Liquigen ®  

Ordered via main stores

06.01.02.03 Liraglutide Victoza®

note liraglutide use for weight management (Saxenda brand) is non-formulary

04.04 Lisdexamfetamine Elvanse®

For use according to licence.

02.05.05.01 Lisinopril 
04.02.03 Lithium Carbonate 

SPECIFY BRAND

04.02.03 Lithium Citrate 

Not dose-equivalent to MR tablets

SPECIFY BRAND

A2.03.01 Locasol ® 

Ordered via main stores

11.04.02 Lodoxamide Alomide®

Restricted Item Ophthalmology only

04.03.01 Lofepramine 
02.12 Lomitapide Lojuxta®

Restricted Item In line with commissioning criteria

08.01.01 Lomustine 
01.04.02 Loperamide 
05.03.01 Lopinavir/ritonavir Kaletra®

Restricted Item For use in licensed indications only.

Not for use in Covid-19 treatment outside of clinical trials. Seek further advice from infection control specialist/pharmacy team.

03.04.01 Loratadine 
04.01.02 Lorazepam 
04.01.02 Lorazepam 
04.08.02 Lorazepam epilepsy
15.01.04.01 Lorazepam 
08.01.05 Lorlatinib Lorviqua®
02.05.05.02 Losartan 
11.04.01 Loteprednol  Lotemax®

unlicensed Note: use for >2 weeks and for indications other than inflammation following ocular surgery is unlicensed.

14.04 Low dose diphtheria, tetanus, acellular pertussis and IPV Repevax ®
14.04 Low dose diphtheria, tetanus, IPV Revaxis ®
13.02.01 Lubricating jelly 
03.07 Lumacaftor + Ivacaftor Orkambi®

Restricted to patients as per NHS England access agreement

09.01.04 Lusutrombopag Mulpleo®
08.01.05 Lutetium (177Lu) oxodotreotride 
05.01.03 Lymecycline 

Restricted Item Dermatology only

13.06.02 Lymecycline 
15.03 Lysine/arginine 

For renal protection during IV radionuclide DOTATATE therapy

02.05.01 Macitentan Opsumit ®

For patients managed under a shared care agreement with the Royal Brompton Hospital only.

01.06.04 Macrogol oral powder 

For chronic constipation/faecal impaction

01.06.04 Macrogol Paediatric oral powder 
01.06.05 Macrogols Moviprep®
09.05.01.03 Magnesium Aspartate Magnaspartate®
09.05.01.03 Magnesium Glycerophosphate Neomag®
09.05.01.03 Magnesium Glycerophosphate 

unlicensed unlicensed

01.06.04 Magnesium Hydroxide Mixture BP 
09.05.01.03 Magnesium oxide 

unlicensed Unlicensed

If compliance problems with magnesium glycerophosphate

09.05.01.03 Magnesium sulfate 

50% (5g in 10ml; 1g in 2ml)

20% (10g in 50ml) unlicensed unlicensed - For use within maternity at Princess Anne hospital

10% (1g in 10ml)

02.03.02 Magnesium sulfate 50% 
13.10.05 Magnesium sulfate paste BP 
01.01.01 Magnesium Trisilicate mixture 
13.10.04 Malathion 0.5% 

note For head and pubic lice. Second line option for scabies.

Self Care Self Care Medicine. Can be purchased OTC (e.g. Derbac-M®).

02.02.05 Mannitol 
03.07 Mannitol inhalation 

In addition to Bronchitol® as per NICE TA 266, Osmohale® is used for diagnostic testing 

05.03.01 Maraviroc Celsentri®
A2.03.01 MCT Pepdite (Nutricia®) 

Ordered through main stores

400g

A2.03.01 MCT Pepdite 1+ (Nutricia®) 

Ordered through main stores

14.04 Measles, Mumps and Rubella Vaccine, Live (MMR) 
05.05.01 Mebendazole 
01.02 Mebeverine 
A2.04.01.02 Medium-chain Triglyceride (MCT) Oil 

Ordered through main stores

500ml

06.04.01.02 Medroxyprogesterone Acetate 
07.03.02.02 Medroxyprogesterone acetate Depo-Provera®/ Sayana Press®
08.03.02 Medroxyprogesterone acetate 
10.01.01 Mefenamic Acid 

Not a first line NSAID.

For dysmenorrhoea and menorrhagia only, but no evidence to support superiority vs other NSAIDs, and safety concerns in overdose. Use only if preferred NSAIDs (naproxen or ibuprofen) not suitable.

05.04.01 Mefloquine 
08.03.02 Megestrol acetate 
04.01.01 Melatonin  Circadin®/ Slenyto®

Restricted Item CAMHS initiation/supervision only for use in children with sleep disorders in accordance with DPC Shared Care guidance.

Tablets may be crushed but this will result in loss of modified-release properties.

unlicensed Note: use of Circadin in this setting will be off label, but is established practice. Current patients established on this formulation may continue.

 

 

04.01.01 Melatonin 3mg 

Restricted Item CAMHS initiation/supervision only for use in children with sleep disorders in accordance with DPC Shared Care guidance

unlicensed Note: use in this setting will be off label, but is established practice. Current patients established on this formulation may continue.

May be crushed/ given via PEG if necessary.

04.01.01 Melatonin 5mg in 5ml 

Restricted Item CAMHS initiation/supervision only for use in children with sleep disorders in accordance with DPC Shared Care guidance

unlicensed Unlicensed special (e.g. Kidmel®, Neomel®)

Only if licensed products are not suitable.

Consider excipients (e.g. sugar, colours, alcohol, sorbitol, propylene glycol) when prescribing for children.

Note: Melatonin 1mg/ml oral solution (Colonis Pharma Ltd) is unlicensed in children aged 0-18 years, and not recommended due to potentially unsafe excipients. This product is therefore non-formulary.

 

10.01.01 Meloxicam 

Restricted Item Existing patients only.

08.01.01 Melphalan 
08.01.01 Melphalan 
04.11 Memantine 

Restricted Item Southern Health - specialist recommended

Oral solution only for patients unable to swallow tablets.

Red Triangle Oral solution comes in different presentations (e.g. pump, dosing pipette, oral syringe) - offer patient counselling on administration method at point of dispensing

 

09.06.06 Menadiol  
14.04 Meningococcal A, C, W135, and Y conjugate vaccine Menveo®
14.04 Meningococcal group B Vaccine Bexsero®
14.04 Meningococcal group C conjugate vaccine 
13.03 Menthol 0.5% in aqueous cream 

note Prescribe by brand name in primary care to avoid specials dispensing (e.g. Arjun®, Dermacool®)

05.04.04 Mepacrine Hydrochloride 

For discoid lupus erythematosus

 unlicensed unlicensed

15.02 Mepivacaine 3% Scandonest Plain®

Restricted Item For specialist use only in Solent Sexual Health Service.

unlicensed For selected patients as intra-cervical block to facilitate insertion of intra-uterine contraception (off-label use) in accordance with FSRH guidance.

03.04.02 Mepolizumab Nucala®
09.08.01 Mercaptamine Cystagon®

Restricted Item In line with NHSE specialist commissioning criteria

11.08 Mercaptamine (cysteamine)  

Restricted Item In line with NHSE specialist commissioning criteria

unlicensed Unlicensed

08.01.03 Mercaptopurine 

unlicensed 10mg tablets are unlicensed

13.05.03 Mercaptopurine dermatology

unlicensed 10mg tablets unlicensed

05.01.02.02 Meropenem 
01.05.01 Mesalazine Pentasa®

Choice of preparation depends on disease location

01.05.01 Mesalazine Salofalk®

Choice of preparation depends on disease location

01.05.01 Mesalazine Octasa®

Choice of preparation depends on disease location

08.01 Mesna 

For urothelial toxicity

13.02.02 Metanium® 

Restricted Item At UHS, second line barrier preparation - for Critical Care and Child Health only

02.07.02 Metaraminol 

unlicensed unlicensed

06.01.02.02 Metformin 
04.07.02 Methadone 10mg/ml 

Restricted Item Palliative Care only

04.10.03 Methadone 1mg/ml  

For management of opioid dependence only.

03.09.01 Methadone Hydrochloride 
18 Methionine 
08.01.03 Methotrexate Haem/Onc
10.01.03 Methotrexate Rheumatology

ONCE WEEKLY

Restricted Item Specialist initiation (unless GP indicates preference to initiate therapy)

13.05.03 Methotrexate dermatology

note Once weekly.

13.05.02 Methoxypsoralen 

Restricted Item Dermatology only - for PUVA

unlicensed Unlicensed

01.06.01 Methycellulose Celevac®
13.08.01 Methyl aminolevulinate Metvix®

Restricted Item Dermatology only

02.05.02 Methyldopa 

Antenatal use

15.03 Methylene blue 0.5% Proveblue®

Licensed for methaemoglobinaemia

Off-label use in septic shock, severe hypotension post-surgery and parathyroid surgery.

04.04 Methylphenidate 
06.03.02 Methylprednisolone 

Amber under specialist protocol for MS relapses

10.01.02.02 Methylprednisolone Acetate Depo-Medrone®
10.01.02.02 Methylprednisolone Acetate Depo-Medrone® with Lidocaine

Pelvic pain clinic

18 Methylthioninium chloride Proveblue®
15.03 Methylthioninium chloride 1% inj  Blue marker®

Licensed as a medical device

04.06 Metoclopramide 

Short term use only. No longer indicated as a motility stimulant

02.02.01 Metolazone 

unlicensed unlicensed

02.04 Metoprolol 

Tablets for initiation, review after 24 hours

02.04 Metoprolol 
05.01.11 Metronidazole 
07.02.02 Metronidazole 

GUM only

13.10.01.02 Metronidazole 0.75%  

note Dermatology initiation for acute exacerbation of rosacea.

Also for fungating tumours.

06.07.03 Metyrapone Metopirone®
10.02.02 Mexiletine Namuscla®

 Commissioned by NHS England for patients with non-dystrophic myotonia within specialised neurosciences centres only

note Note: mexiletine also approved locally as amber for cardiology use only (see section 2.3.2).

(167mg mexiletine = 200mg mexiletine hydrochloride)

02.03.02 Mexiletine hydrochloride 

Restricted Item Cardiology use only  unlicensed unlicensed.

 

note Note: also approved as red for myotonia (see section 10.2.2)

05.02.04 Micafungin 

Restricted Item Specialist use only

07.02.02 Miconazole 
12.03.02 Miconazole 
13.10.02 Miconazole 2% 

note Can be purchased OTC.

15.01.04.01 Midazolam premedication/sedation

Injection is Green for use in palliative care

Liquid is unlicensed unlicensed

15.01.04.01 Midazolam premedication

Red for off-label use prior to endoscopy for adults and children >10 years who do not tolerate IV cannulation

See also section 4.8.2

04.08.02 Midazolam buccal liquid seizures

unlicensed unlicensed

Child Health only

04.08.02 Midazolam oromucosal solution seizures

Amber for children with a seizure disorder

06.01.05 Midodrine 
08.01.05 Midostaurin 
08.02.04 Mifamurtide 
07.01.02 Mifepristone 
02.01.02 Milrinone Primacor®

Restricted Item  Critical Care only

02.05.01 Minoxidil 
07.04.02 Mirabegron 

Restricted Item Only if antimuscarinics are contraindicated or ineffective, or have unacceptable side effects

04.03.04 Mirtazapine 

Orodispersible tabs restricted to patients with swallowing difficulties

07.01.01 Misoprostol 

For termination of pregnancy

08.01.02 Mitomycin 
08.01.05 Mitotane 

palliative use in adrenal carcinoma

08.01.02 Mitoxantrone 
15.01.05 Mivacurium Mivacron®

Restricted Item Specialist use only

04.04 Modafinil 

Restricted Item Restricted use. For treatment of excessive sleepiness associated with narcolepsy only. Prescribing to be initiated by sleep specialist/neurologist.

Caution: prescribers should be aware of abuse risk (Modafinil: Be Smart) when considering quantities on prescriptions.

Modafinil is not supported for use (off-label) in any other indications in accordance with MHRA safety alert 2011.

 

A2.03.02 Modulen IBD ®  

Ordered via main stores

12.02.01 Mometasone Furoate 

First line for children and for treatment of nasal polyps in adults

Second line to beclometasone propionate in adults for seasonal allergic or perennial rhinitis

 

13.04 Mometasone furoate 0.1% 
A2.03.01 Monogen® 

Ordered through main stores

400g

03.03.02 Montelukast 

Restricted Item Granules for use only if unable to take alternative formulations

04.07.02 Morphine sulphate 

Zomorph MR cap is first line oral morphine MR product.

unlicensed unlicensed suppositories

12.03.04 Mouthwash solution tab 
05.01.12 Moxifloxacin 
05.01.12 Moxifloxacin 
02.05.02 Moxonidine 

Restricted Item  Specialist use only

A2.07 MSUD Anamix ® Infant 

Ordered via main stores

09.06.07 Multivitamin  
09.06.07 Multivitamin preparations Abidec®

Alternative to Dalivit drops on Neonatal Unit

09.06.07 Multivitamin preparations Dalivit®
12.02.03 Mupirocin 2% Bactroban Nasal®

Restricted Item For MRSA only

13.10.01.01 Mupirocin 2% 
08.02.01 Mycophenolate mofetil 

Red Red for renal transplant
Amber Amber for all other indications

Second line for resistant nephrotic syndrome, SLE nephritis

08.02.01 Mycophenolate mofetil 
13.05.03 Mycophenolate sodium (mycophenolic acid) dermatology

Restricted Item Dermatology only

unlicensed Off label use

11.05 Mydricaine No. 2  

unlicensed Unlicensed

10.01.01 Nabumetone 

Not a first line NSAID

02.06.04 Naftidrofuryl 
04.10.01 Nalmefene 

Only in conjunction with continuous psychosocial support.

01.06.06 Naloxegol Moventig ®
15.01.07 Naloxone 
18 Naloxone 
04.10.01 Naltrexone Adepend®

Recommended by alcohol detoxification service.

04.10.03 Naltrexone Nalorex®
10.01.01 Naproxen 

A first line NSAID

08.02.04 Natalizumab 
A2.03.01 Neocate® junior 

Ordered through main stores

400g

A2.03.01 Neocate® LCP 

Ordered via main stores

A2.03.01 Neocate® spoon 

Ordered through main stores

05.01.04 Neomycin Sulphate 

Restricted Item Cancer care for gut sterilisation prior to BMT

unlicensed Liquid is unlicensed

10.02.01 Neostigmine 
15.01.06 Neostigmine  
08.01.05 Neratinib Nerlynx®
04.06 Netupitant and Palonosetron Akynzeo®

For prevention of chemotherapy-induced nausea/vomiting

05.03.01 Nevirapine 
02.06.03 Nicorandil 

For stable angina in accordance with NICE Guidelines

04.10.02 Nicotine Replacement Therapy 

Formulary options - Nicotine patch [Nicorette Invisi patches]/Nicorette icy white gum/Nicorette inhalator/Nicorette Quickmist mouthspray.

As part of a smoking cessation programme.

02.06.02 Nifedipine 

Prescribe by brand name, e.g. Adalat LA®, Adipine XL®, Coracten XL®

02.06.02 Nifedipine 

Prescribe by brand name, e.g. Adalat Retard®, Adipine MR®, Coracten SR®

02.06.02 Nifedipine 

Immediate release formulation for treatment of Raynaud's phenomenon.

Modified-release formulations preferred for other indications, including treatment of hypertension, angina prophylaxis and tocolysis.

Red Triangle Not recommended for (off label) sublingual administration.

07.01.03 Nifedipine 

unlicensed Off-label use for tocolysis in accordance with UHS guideline

08.01.05 Nilotinib 
02.06.02 Nimodipine Nimotop®

For subarachnoid haemorrhage

02.06.02 Nimodipine Nimotop®

For subarachnoid haemorrhage

08.01.05 Nintedanib 

Vargatef branf for NSCLC, Ofev brand for IPF in line with NICE guidance (see links)

08.01.05 Niraparib 
04.01.01 Nitrazepam 
05.01.13 Nitrofurantoin 
08.01.05 Nivolumab Opdivo®

For untreated advanced renal cell carcinoma: available through Cancer Drugs Fund, only if conditions in the managed access agreement are followed.

01.03.01 Nizatidine 

Restricted Item For use only as an alternative H2-antagonist when ranitidine is not available, and a proton pump inhibitor is not suitable.

07.03.01 Nomegestrol acetate and beta estradiol  Zoely®

Restricted Item Consultant use at Solent NHS Trust only

07.03.03 Nonoxinol-9 
02.07.02 Noradrenaline 
06.04.01.02 Norethisterone 
08.03.02 Norethisterone 
07.03.02.01 Norethisterone 350 microgram Noriday®
07.03.02.02 Norethisterone enantate Noristerat®

For short term, interim contraception

05.01.12 Norfloxacin 
14.05.01 Normal immunoglobulin for Intravenous use 

National Demand Management Programme - Request form must be completed

Specify brand

Specialist use only

14.05.01 Normal immunoglobulin for Subcutaneous use 

National Demand Management Programme - Request form must be completed

Specify brand

Specialist use only

10.02 Nusinersen Spinraza ®

For use in spinal muscular atrophy (SMA) in line with NHSE specialised commissioning criteria

 

A2.03.01 Nutramigen® 1 with LGG 

Ordered via main stores

A2.03.01 Nutramigen® Puramino 

Ordered via main stores

A2.03.01 Nutricia® essential amino acid mix 

Ordered through main stores

A2.01.03.04 Nutrini ® Energy Multifibre 

8 x 500ml stocked in pharmacy

A2.01.03.02 Nutrini ®Multifibre 

8 x 500ml stocked in pharmacy.

For paediatric wards only

A2.01.03.02 Nutrini ® 

8 x 500ml stocked in pharmacy

For paediatric wards only

A2.01.03.01 Nutrini ®Low Energy Multifibre 

Not held in stock but available to order through pharmacy

Restricted to use in paediatrics only

12 x 200ml/8 x 500ml

A2.01.03.02 Nutrini ®Peptisorb 

8 x 500ml stocked in pharmacy

A2.01.03.04 Nutrini Energy ® 

8 x 500ml stocked in pharmacy

Paediatric wards only

A2.01.03.04 Nutrini energy peptisorb® 

Not held in stock but available to order through pharmacy

8 x 500ml

A2.03.01 Nutriprem 2 (Cow and Gate®) 

Ordered through main stores

90ml

A2.05.02 Nutriprem Breast Milk Fortifier (Cow & Gate®) 

Ordered via main stores

A2.03.01 Nutriprem protein supplement (Cow and Gate®) 

Ordered through main stores

A2.01.03.01 Nutriprem® 2  
A2.01.01.01 Nutrison ®  

8 x 500ml stocked in Pharmacy

8 x 1000ml 6 x 1500ml not held in stock but available to order through pharmacy

A2.01.02.01 Nutrison ® Energy 

8 x 500ml stocked in pharmacy

8 x 1000ml/6 x 1500ml not held in stock but available to order through pharmacy

A2.01.02.01 Nutrison ® Energy Multi Fibre 

8 x 500ml stocked in pharmacy

8 x 1000ml 6 x 1500ml not held in stock but available to order through pharmacy

A2.01.02.02 Nutrison ® MCT 

8 x 1000ml stocked in pharmacy

A2.01.01.01 Nutrison ® Multi Fibre 

8 x 500ml stocked in pharmacy

8 x 1000ml/6 x 1500ml not held in stock but available to order through pharmacy

A2.01.02.02 Nutrison ® Protein Plus 

8 x 1000ml stocked in pharmacy

A2.01.02.02 Nutrison ® Protein Plus Multi Fibre 

8 x 1000ml stocked in pharmacy

A2.01.01.01 Nutrison ® Soya 

Not held in stock but available to order through pharmacy

8 x 1000ml

A2.01.01.01 Nutrison ® Soya Multi Fibre 

Not held in stock but available to order through pharmacy

6 x 1500ml

A2.01.02.02 Nutrison ® 1000 Complete Multi Fibre 

Not held in stock but available to order through pharmacy

8 x 1000ml

A2.01.02.02 Nutrison ® 1200 Complete Multi Fibre 

Not held in stock but available to order through pharmacy

8 x 1000ml

A2.02.02.01 Nutrison ® Energy Multi Fibre 

8 x 500ml stocked in pharmacy

A2.01.01.01 Nutrison® Advanced Peptisorb 

8 x 500ml stocked in pharmacy

8 x 1000ml Not held in stock but available to order through pharmacy

A2.01.02.03 Nutrison® Concentrated 

8 x 500ml stocked in pharmacy

A2.01.01.01 Nutrison® Low Sodium 

8 x 1000ml stocked in pharmacy

12.03.02 Nystatin 
01.09.01 Obeticholic acid Ocaliva®
08.02.03 Obinutuzumab 
08.02.04 Ocrelizumab Ocrevus®
11.08.02 Ocriplasmin Jetrea®
13.11 Octenidine 0.3%  Octenisan®

From NHS logistics

08.03.04.03 Octreotide 
08.03.04.03 Octreotide Sandostatin Lar®

First choice for acromegaly

06.04.01.01 Oestrogen only HRT tablet Elleste-Solo
06.04.01.01 Oestrogens for HRT Progynova®
06.04.01.01 Oestrogens for HRT Elleste-Duet Conti®
08.02.03 Ofatumumab 
05.01.12 Ofloxacin 
05.01.12 Ofloxacin 
11.03.01 Ofloxacin  

Restricted Item Ophthalmology only 

13.02.01.01 Oilatum® Emollient 

note Contains fragrance.

Consider Zerolatum as more cost-effective alternative.

01.07.03 Oily Phenol 5% 
04.02.01 Olanzapine 

Orodispersible tablets restricted to patients with swallowing difficulties

08.01.05 Olaparib Lynparza®

note Note: NICE TA598 and TA620 only cover use of tablet formulation (not capsules)

08.01.05 Olaratumab 
12.01.03 Olive Oil Ear Drops 
03.01.01.01 Olodaterol Striverdi Respimat®

note Prescribe by brand name.

Licensed for COPD only, not for asthma

11.04.02 Olopatadine Opatanol®

Restricted Item Ophthalmology only

03.04.02 Omalizumab Xolair®

Occasionally used in primary care

05.03.03.02 Ombitasvir/ paritaprevir/ ritonavir Viekirax®
01.03.05 Omeprazole 

Restricted Item Dispersible tabs only for paediatric patients or patients with swallowing difficulties

01.03.05 Omeprazole 20mg in 5ml 

Restricted Item Specialist recommendation only for paediatric patients when dispersible tabs are not appropriate.

Available as licensed preparation (Rosemont), suitable for enteral tube administration. Powder should be reconstituted by pharmacist prior to dispensing to the patient (see product SPC).

note Lansoprazole orodispersible tablets preferred in adults with swallowing difficulties/enteral tube administration.

04.06 Ondansetron 
04.09.01 Opicapone Ongentys®
12.03.01 Orabase® 

Self Care Available OTC

09.02.01.02 Oral Rehydration Salts 

Blue - Electrolade on FP10

03.04.02 Oralvac compact® 

unlicensed unlicensed

Restricted Item Specialist allergy clinics only. For use only when licensed alternatives are not suitable.

 

04.05.01 Orlistat 
04.09.02 Orphenadrine 
05.03.04 Oseltamivir 

Restricted Item In line with NICE TAs or pandemic flu

08.01.05 Osimertinib 
08.01.05 Oxaliplatin 
06.04.03 Oxandrolone 

unlicensed unlicensed

04.10.01 Oxazepam 

Off label use

UHS users see local guidelines

04.08.01 Oxcarbazepine 
11.07 Oxybuprocaine Minims®
07.04.02 Oxybutynin 

note First line for urinary incontinence (refer to local guidelines and NICE CG171). May also be used for treatment of hyperhidrosis (off-label use).

Not suitable for frail older women or patients with cognitive impairment.

07.04.02 Oxybutynin 
07.04.02 Oxybutynin Lyrinel XL®

Restricted Item MR tablets for existing patients only. 

04.07.02 Oxycodone 

In UHS, capsules and liquid are GREEN for patients who have previously been prescribed oxycodone MR due to intolerance to morphine

Capsules only for patients unable to tolerate liquid, not for ward stock

Restricted Item Liquid is RED in UHS for patients who require oral treatment after oxycodone PCA. Acute Pain Team recommendation only 

04.07.02 Oxycodone 

Restricted Item Amber for use in palliative care in the community, otherwise acute pain team only

Second line PCA

05.01.03 Oxytetracycline 
13.06.02 Oxytetracycline 
07.01.01 Oxytocin 
08.01.05 Paclitaxel 
08.01.05 Paclitaxel - Albumin Bound  
A2.02.01.01 Paediasure Peptide® 

200ml/500ml stocked in pharmacy.

Paediatric wards only

A2.02.01.02 Paediasure Plus Juce® 

Not held in stock but available to order through pharmacy

200ml - Apple/Very Berry

A2.01.03.04 Paediasure Plus® 

Not held in stock but available to order through pharmacy

200ml  - Banana/Strawberry/Vanilla

A2.04.02 Paediatric Seravit ®  

Not held in stock but available to order through pharmacy

200g

08.01.05 Palbociclib Ibrance®
04.02.02 Paliperidone palmitate Xeplion / Trevicta®

Restricted Item  Specialist use at Southern Health/Solent NHS Trust

note For intramuscular injection. Xeplion = 1-monthly, Trevicta = 3-monthly maintenance dosing.

05.03.05 Palivizumab Synagis®

Restricted Item Commissioned by NHS England (for RSV prophylaxis) for children in the groups outlined in Specialised Commissioning Circular 1937.

09.05.01.02 Pamidronate disodium 
01.09.04 Pancreatin Pancrex® V
01.09.04 Pancreatin Creon®
15.01.05 Pancuronium 
08.01.05 Panitumumab 
08.01.05 Panobinostat 
01.03.05 Pantoprazole 
02.06.04 Papaverine 

unlicensed unlicensed

04.07.01 Paracetamol 
04.07.01 Paracetamol 

Injection only if oral/rectal routes are unavailable or inappropriate

04.07.03 Paracetamol 

First line for neuropathic pain

04.07.04.01 Paracetamol 

Soluble or dispersible form preferred +/- metoclopramide

04.07.01 Paracetamol and codeine Co-codamol 30/500

Restricted Item Effervescent tablets restricted to patients with swallowing difficulties/enteral feeding tubes.

04.07.01 Paracetamol and codeine Co-codamol 8/500

Soluble preparations have a high sodium content

04.07.01 Paracetamol and dihydrocodeine Co-dydramol 10/500
04.08.02 Paraldehyde and olive oil enema 

unlicensed unlicensed

09.06.07 Paravit-CF 

Fat-soluble vitamin supplements for use when recommended by specialist in patients with cystic fibrosis.

Specialists to ensure preferred formulation and dose is clearly communicated to primary care prescribers.

15.01.04.02 Parecoxib Dynastat®

Restricted Item unlicensed Off label use by subcutaneous injection/infusion in palliative care only; to be prescribed and administered under specialist supervision

03.12 PARI O-PEP® 

Oscillating Positive Expiratory Pressure (OPEP) device.

Restricted Item For initiation by specialist physiotherapist or respiratory clinician only. For airways clearance in selected patients with chronic sputum-producing lung disease, e.g. cystic fibrosis, bronchiectasis, COPD.

All follow up and monitoring of patients, and routine replacement of devices to be carried out in secondary care. 

Primary care prescribing on FP10 only when required for urgent supply of additional/replacement device (Drug Tariff listed approved appliance).

04.03.03 Paroxetine 
15.03 Patent Blue V® 2.5% 

unlicensed unlicensed

Product of choice for sentinel lymph node biopsies

09.02.01.01 Patiromer sorbitex calcium Veltassa®

Red for acute use

Amber Initiation for chronic use

For use only in accordance with recommendations in NICE TA623

08.01.05 Pazopanib 
08.01.05 Pegaspargase Oncaspar®
09.01.06 Pegfilgrastim 

Restricted Item For sarcoma only

05.03.03 Peginterferon alfa-2a Pegasys®
08.02.04 Peginterferon Alfa-2a Pegasys®
05.03.03 Peginterferon Alfa-2b ViraferonPeg®
08.02.04 Peginterferon Alfa-2b ViraferonPeg®
08.02.04 Peginterferon Beta-1a Plegridy®

Restricted Item Specialist use only

06.05.01 Pegvisomant Somavert®

Restricted Item As per NHSE commissioning criteria

07.05 PelvicTonerTM device 

Restricted Item Medical device listed in Drug Tariff. Supported by District Prescribing Committee (Dec 2011) for prescribing in primary care only for use in accordance with NICE recommendations for management of urinary incontinence, as an aid to pelvic floor muscle training.

 

08.01.05 Pembrolizumab Keytruda®

50mg powder for concentrate for solution for infusion is black triangle

08.01.03 Pemetrexed 
10.01.03 Penicillamine 
11.03.01 Penicillin G (Benzylpenicillin)  

unlicensed unlicensed 

Restricted Item Ophthalmology only

05.04.08 Pentamidine Isetionate 
07.04.03 Pentosan polysulfate sodium Elmiron®

DPC April 2018 for bladder pain syndrome/interstitial cystitis

A2.03.01 Pepdite 1+ 

Ordered through main stores

01.02 Peppermint Oil Mintec®
01.01.02 Peptac ® 

First line choice in primary care

A2.01.02.02 Peptamen ® HN 

Not held in stock but available to order through pharmacy

500ml

A2.01.02.01 Peptamen® AF  

Not held in stock but available to order through pharmacy

500ml 

A2.03.01 Peptamen® junior 

Ordered through main stores

04.08.01 Perampanel Fycompa®

Restricted Item  Treatment initiated and patients stabilised by neurology specialists

11.08.02 Perfluorodecalin (perflunafene) 

unlicensed unlicensed

04.09.01 Pergolide 
01.06.05 Peristeen® anal irrigation system 

Approved appliance (refer to part IX of NHS England and Wales Drug Tariff)

For neurogenic bowel dysfunction

13.10.04 Permethrin 5% 

note First line for scabies. 

Self Care Self Care Medicine. Can be purchased OTC.

08.01.05 Pertuzumab 
04.07.02 Pethidine 
04.07.02 Pethidine 
04.03.02 Phenelzine Nardil®

Restricted Item Specialist use only

02.08.02 Phenindione 
04.08.01 Phenobarbital 

Restricted Item Child Health and existing patients only

04.08.02 Phenobarbital 
04.08.01 Phenobarbital elixir 

unlicensed unlicensed

Restricted Item Specialist use only

02.05.04 Phenoxybenzamine Hydrochloride 
05.01.01.01 Phenoxymethylpenicillin penicillin V
02.05.04 Phentolamine 

unlicensed unlicensed

Restricted Item  Critical Care only

10.01.01 Phenylbutazone 

Restricted Item Specialist use only

02.07.02 Phenylephrine 

First line for acute hypotension

11.05 Phenylephrine  Minims®

Preservative-free.

11.05 Phenylephrine and tropicamide ophthalmic insert Mydriasert®
04.07.03 Phenytoin 

For trigeminal neuralgia if carbamazepine is ineffective or not tolerated

04.08.01 Phenytoin 

Preparations containing phenytoin sodium are not bioequivalent to those containing phenytoin base. 

04.08.02 Phenytoin 
02.03.02 Phenytoin sodium 

Restricted Item Cardiology use only

03.09.01 Pholcodine Linctus, BP 
09.05.02.01 Phosphate supplements Phosphate-Sandoz®
01.06.04 Phosphates (Rectal) 
02.08.03 Phytomenadione Konakion MM ®

Konakion MM Paediatric injection can be given orally

09.06.06 Phytomenadione Neokay

TTO use only

The contents of one capsule should be administered by cutting the narrow tubular tip off and squeezing the liquid contents into the mouth.

09.06.06 Phytomenadione 

Tablets are unlicensed unlicensed

Konakion MM paediatric injection can be given orally

01.06.05 Picolax ® 
11.06 Pilocarpine 
11.06 Pilocarpine 2% 

Preservative-free.

Restricted Item Only for patients allergic/intolerant of preservatives, or high risk of developing allergy.

13.05.03 Pimecrolimus Elidel®
06.01.02.03 Pioglitazone 
05.01.01.04 Piperacillin and Tazobactam 
04.02.02 Pipotiazine palmitate Piportil® Depot

Restricted Item  Southern Health only

note For deep intramuscular injection

04.09.03 Piracetam Nootropil®

Restricted Item Specialist initiation only

For the treatment of severe myoclonic epilepsy

04.12 Pirenzepine 

Restricted ItemSpecialist use at Southern Health only.

unlicensed unlicensed

03.11 Pirfenidone 
04.04 Pitolisant Wakix®

Restricted Item Restricted use. For specialist sleep clinic use for treatment of narcolepsy in patients aged ≥18 years, only when conventional stimulants have failed/not tolerated, and sodium oxybate is not suitable/not tolerated as per DPC recommendations.

05.01.01.05 Pivmecillinam 

Restricted Item Microbiology recommendation only

08.01.02 Pixantrone 
04.07.04.02 Pizotifen 
A2.07 PKU Anamix ® Infant 

Ordered via main stores

09.02.02.01 Plasma-Lyte 148; Plasma-Lyte 148 with Glucose 5% 

Restricted Item For use in Southampton Children’s Hospital as alternative to compound sodium lactate (Hartmann’s) and as standard fluid of choice.

note Contains potassium (K+) 5mmol/L

13.14 Plaster remover 
09.01.07 Plerixafor 

For use as per commissioning criteria set by NHS England

14.04 Pneumococcal polysaccharide conjugate vaccine (13-valent adsorbed) 
13.07 Podophyllin Compound Paint BP 

note Contains podophyllum resin 0.15% w/v.

13.07 Podophyllotoxin 0.15% 
13.07 Podophyllotoxin 0.5% 
11.03.01 Polihexanide (Polyhexamethylene) PHMB

unlicensed unlicensed

Restricted Item Ophthalmology only

06.01.06 Polycal ® 
A2.04.01.01 Polycal ®  

Not held in stock but available to order through pharmacy

200ml - Neutral

Polycal powder ordered via main stores

14.04 Polysaccharide Typhoid Vaccine 
11.08.01 Polyvinyl alcohol 1.4% Liquifilm Tears or Sno Tears®

note To be used in line with DPC dry eye guidelines (link below)

Restricted Item Unit dose drops only for patients allergic/intolerant of preservatives or high risk of developing allergy

08.02.04 Pomalidomide Imnovid®
08.01.05 Ponatinib 
03.05.02 Poractant Alfa 

Restricted Item Neonatal unit only

05.02.01 Posaconazole  

Restricted Item Specialist use only

11.99.99.99 Potassium ascorbate (ascorbic acid) 

unlicensed Unlicensed special

note Preservative-free. For chemical burns.

02.02.03 Potassium canrenoate 

unlicensed unlicensed

09.02.01.01 Potassium Chloride Sando-K®
09.02.01.01 Potassium Chloride Kay-Cee-L®
09.02.01.01 Potassium Chloride Slow-K®
09.02.02.01 Potassium Chloride and Glucose Intravenous Infusion  

Potassium chloride 0.2% and glucose 5% (containing approx. 13.5mmol potassium chloride) 500ml bags

Potassium chloride 0.2% and glucose 5% (containing approx. 27mmol potassium chloride) 1L bags

Potassium chloride 0.3% and glucose 5% (containing 40mmol potassium chloride) 1L bags

09.02.02.01 Potassium Chloride and Sodium Chloride Intravenous Infusion 

Potassium chloride 0.15%, sodium chloride 0.45% and glucose 5% (containing 10mmol potassium chloride) 500ml bags

Potassium chloride 0.15%, sodium chloride 0.45% and glucose 10% (containing 10mmol potassium chloride) 500ml bags

Potassium chloride 0.15%, sodium chloride 0.18% and glucose 10% (containing 10mmol potassium chloride) 500ml bags

Potassium chloride 0.2% and glucose 5% (containing approx. 13.5mmol potassium chloride) 500ml bags

Potassium chloride 0.2% and glucose 5% (containing approx. 27mmol potassium chloride) 1L bags

Potassium chloride 0.2% and sodium chloride 0.9% (containing approx. 13.5mmol potassium chloride) 500ml bags

Potassium chloride 0.2% and sodium chloride 0.9% (containing approx. 27mmol potassium chloride) 1L bags

Potassium chloride 0.2%, glucose 4% and sodium chloride 0.18% (containing approx. 13.5mmol potassium chloride) 500ml bags

Potassium chloride 0.2%, glucose 4% and sodium chloride 0.18% (containing approx. 27mmol potassium chloride) 1L bags

Potassium chloride 0.3% and sodium chloride 0.9% (containing 20mmol potassium chloride) 500ml bags

Potassium chloride 0.3% and sodium chloride 0.9% (containing 40mmol potassium chloride) 1L bags

Potassium chloride 0.3%, sodium chloride 0.45% and glucose 5% (containing 20mmol potassium chloride) 500ml bags

07.04.03 Potassium Citrate 
13.11.06 Potassium permanganate Permitabs®

Red Triangle Should be dispensed in original container (i.e. as whole pack) only (see safety bulletin on risks of accidental ingestion below).

13.11.04 Povidone iodine 10% 

From NHS Logistics.

13.11.04 Povidone iodine 10% 

From NHS Logistics.

12.04 Povidone iodine 10% in boric acid powder 

unlicensed Unlicensed

13.11.04 Povidone iodine 2.5% 
13.11.04 Povidone iodine 7.5% 

From NHS Logistics.

18 Pralidoxime chloride Protopam®
04.09.01 Pramipexole 

Check base/salt equivalence

04.09.04 Pramipexole 

Specialist use only 

Third/fourth line for restless legs syndrome

02.09 Prasugrel Efient®
02.12 Pravastatin  
01.05.02 Prednisolone 

Restricted Item Rectal foam for use in paediatrics only

06.03.02 Prednisolone 

Red Triangle Not enteric coated tablets

See DPC Summary June 2018 for recommendations on dissolving or crushing plain prednisolone tablets.

10.01.02.01 Prednisolone 

Not EC tablet

11.04.01 Prednisolone 
11.04.01 Prednisolone acetate Pred Forte®
04.07.03 Pregabalin 

For neuropathic pain in accordance with NICE Guidelines

Also amber for epilepsy and green for generalised anxiety disorder (see section 4.8.1)

04.08.01 Pregabalin 

Amber Recommended Amber for epilepsy (not a first line choice)

Green Green for generalised anxiety disorder

Also green for neuropathic pain (see section 4.7.3)                                                      

 

A2.03.01 Pregestimil ® lipil 

Ordered via main stores

A2.03 preOP® 

24 x 200ml stocked in pharmacy

For enhanced recovery surgery

15.02 Prilocaine Hydrochloride 1%/2% 
15.02 Prilocaine Hydrochloride with Felypressin 
05.04.01 Primaquine 

unlicensed unlicensed

Restricted Item microbiology recommendation only

05.04.08 Primaquine  

unlicensed unlicensed

04.08.01 Primidone 

Existing patients only

02.03.02 Procainamide 

unlicensed unlicensed.

Restricted Item Cardiology use only.

08.01.05 Procarbazine 
04.06 Prochlorperazine 

Buccal tabs are an alternative to injectable antiemetics.

01.07.02 Proctosedyl ® 

Local anaesthetic plus steroid

04.09.02 Procyclidine 
13.10.05 Proflavine 0.1% 
06.04.01.02 Progesterone (micronised) 100mg Utrogestan®

For oral administration as HRT.

06.04.01.02 Progesterone (micronised) 200mg Utrogestan ®

Restricted Item For emergency supply to patients treated by the fertility unit only

06.04.01.02 Progestogen  pessaries
05.04.01 Proguanil Hydrochloride with Atovaquone Malarone®
04.02.01 Promazine Hydrochloride 

Injection is unlicensed unlicensed 

03.04.01 Promethazine 
03.04.01 Promethazine 
04.06 Promethazine 

 

  • 10mg, 25mg tablets
  • 5mg/5ml elixir
02.03.02 Propafenone 

Restricted Item Cardiology only.

11.03.01 Propamidine isetionate Brolene®

'Off label' use for Acanthamoeba infections

01.02 Propantheline bromide 

Also off-label for diabetic neuropathy

13.12 Propantheline bromide Pro-Banthine®

note For hyperhidrosis (licensed indication), or consider oxybutynin or trospium (off-label).

15.01.01 Propofol 
02.04 Propranolol 
02.04 Propranolol 

unlicensed unlicensed

04.07.04.02 Propranolol 
06.02.02 Propranolol 

For rapid relief of thyrotoxic symptoms

06.02.02 Propranolol 

For rapid relief of thyrotoxic symptoms

11.08.01 Propylene glycol 0.3% and polyethylene glycol 0.4% Systane® Preservative-free

note To be used in line with DPC dry eye guidelines (link below)

Restricted Item Only for patients requiring a preservative-free alternative to propylene glycol [Systane Balance] eye drops

11.08.01 Propylene glycol 0.6%  Systane Balance®

note To be used in line with DPC dry eye guidelines (link below)

13.02.01 Propylene glycol in aqueous cream 

note From British Association of Dermatologists (BAD) Specials List 2014.

unlicensed Unlicensed. 

Restricted Item Dermatology recommendation only.

Use when urea based products are ineffective, unsuitable or not tolerated.

Can also be used as a barrier cream

06.02.02 Propylthiouracil 
A2.04.01.03 ProSource ® TF Liquid 

Not held in stock but available to order through pharmacy

100 x 45ml

02.08.03 Protamine sulfate 
06.01.06 Protein test strips Albustix®
06.05.01 Protirelin TRH

unlicensed unlicensed

11.07 Proxymetacaine Minims®
01.06.07 Prucalopride Resolor®
03.10 Pseudoephedrine Hydrochloride 

Off-label use for emergency treatment of priapism

05.01.09 Pyrazinamide 
10.02.01 Pyridostigmine Bromide 
04.08.02 Pyridoxine 

unlicensed unlicensed

Restricted Item Child Health only.

09.06.02 Pyridoxine Hydrochloride 
05.04.07 Pyrimethamine 
05.04.01 Pyrimethamine with Sulfadoxine 

unlicensed unlicensed

04.02.01 Quetiapine 
05.04.01 Quinine dihydrochloride 

unlicensed unlicensed

05.04.01 Quinine sulfate 
10.02.02 Quinine sulfate 
14.05.02 Rabies immunoglobulin 

Microbiology request only

14.04 Rabies vaccine 

Restricted Item Restricted for use in line with post-exposure prophylaxis guidelines only (see staffnet)

08.03.04.02 Radium-223 dichloride 

Radiopharmaceutical to be administered only by authorised persons

06.04.01.01 Raloxifene Hydrochloride 

Osteoporosis - Second line

05.03.01 Raltegravir 
02.05.05.01 Ramipril 
11.08.02 Ranibizumab 
01.03.01 Ranitidine 
01.03.01 Ranitidine 
02.06.03 Ranolazine Ranexa®

Restricted Item Specialist recommendation only. Third-line option for stable angina where other anti-anginals are contraindicated/not tolerated due to hypotensive and/or bradycardic effects and revascularisation options not available.

04.09.01 Rasagiline 

First choice MAO-B inhibitor

10.01.04 Rasburicase Fastertec®

Oncology only

04.03.04 Reboxetine 
02.14 Regadenoson 

unlicensed unlicensed

For use during radionuclide myocardial perfusion scanning

08.01.05 Regorafenib Stivarga®
05.03 Remdesivir 

unlicensed Unlicensed Medicine

Yellow Card Yellow Card Reporting (Adverse Drug Reactions)

Restricted Item For use only in the treatment of patients hopitalised with suspected or laboratory-confirmed SARS-CoV-2 infection who meet the clinical criteria.

See Management of COVID-19 patients (via UHS staffnet) for the treatment and supply process

15.01.04.03 Remifentanil Ultiva®

Restricted Item Theatres and patient controlled analgesia during labour

A2.03.02 Renastart ®  

Ordered via main stores

03.04.02 Reslizumab 
02.10.02 Reteplase Rapilysin®
05.03.03.02 Ribavirin 
05.03.05 Ribavirin 

Restricted Item Specialist use only 

unlicensed Injection is unlicensed

08.01.05 Ribociclib Kisqali®
05.01.09 Rifabutin 

For mycobacterium avium prophylaxis

05.01.10 Rifampicin 

Red Red for tuberculosis
Amber Amber for other infections

05.01.09 Rifampicin and Isoniazid 
05.01.09 Rifampicin, Isoniazid and Pyrazinamide Rifater®
05.01.09 Rifampicin, isoniazid, pyrazinamide and ethambutol Voractiv®
05.01.07 Rifaximin 

Amber for hepatic encephalopathy

Red Third line treatment for small intestine bacterial overgrowth. Specialist use only as per UHS guideline

05.03.01 Rilpivirine hydrochloride 
04.09.03 Riluzole Rilutek®
09.02.02.01 Ringers Solution 
06.06.02 Risedronate 
04.02.01 Risperidone 

Orodispersible tablets restricted to patients with swallowing difficulties

04.02.02 Risperidone Risperdal Consta®

Restricted Item  Psychiatry only

note For deep intramuscular injection

05.03.01 Ritonavir 
08.02.03 Rituximab/ rituximab biosimilar MabThera®, Rixathon®, Truxima®) (Haematology

Restricted Item Specialist use only

Also for ITP and refractory autoimmune haemolytic anaemia

note Specify brand.

Rixathon and Truxima black triangle

10.01.03 Rituximab/rituximab biosimilar MabThera®, Rixathon®, Truxima®) (Rheumatology

Also for pemphigus vulgaris (MabThera brand only).

unlicensed off label use in pemphigoid, nephrotic syndrome in children, systemic lupus erythematosus in adult patients.

note Specify brand

Rixathon and Truxima black triangle

 

02.08.02 Rivaroxaban Xarelto®) (AF/VTE
02.08.02 Rivaroxaban Xarelto®) (Orthopaedic prophylaxis

  • red for trauma (off-label use)
  • red for off-label use for patients with fractured neck of femur or who have a plaster cast and who fulfil the assessment criteria
02.08.02 Rivaroxaban Xarelto®) (ACS
04.11 Rivastigmine 

Liquid only for patients unable to swallow capsules

Also for dopaminergic drug-induced psychosis as 'Off-label use'

15.01.05 Rocuronium Esmeron®
03.03.03 Roflumilast 
09.01.04 Romiplostim Nplate®
04.09.01 Ropinirole 

An initial choice, particularly in younger patients.

02.12 Rosuvastatin 

Restricted Item Reserved for use in patients requiring high intensity statin unable to tolerate/unsuitable for atorvastatin or high dose simvastatin

14.04 Rotavirus vaccine Rotarix®
04.09.01 Rotigotine 

Initiated/recommended by specialists only.

A replacement for oral dopamine agonists in patients with inadequate control of nocturnal/early morning symptoms.

In patients with inadequate compliance of complex regimens (cognitive problems, unable to swallow oral medication, motor problems).

As sole treatment in emergency situations when patients are unable to swallow oral drugs

08.01.05 Rucaparib Rubraca®
04.08.01 Rufinamide Inovelon®

Restricted Item Initiated by Paediatric Neurologists for Lennox Gastaut syndrome

08.01.05 Ruxolitinib Jakavi®
02.05.05.02 Sacubitril valsartan Entresto®
04.09.01 Safinamide 

Restricted Item Restricted to use in late-stage Parkinson’s Disease and motor fluctuations where treatment with rasagiline/selegiline and entacapone has failed/not tolerated

03.01.01.01 Salbutamol 

note Prescribe breath-actuated MDIs and DPIs by brand name

13.07 Salicylic acid 

note May be purchased OTC. 

For palmar/plantar warts, corns, calluses.

13.07 Salicylic acid 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.05 Salicylic acid 2% & sulphur 2% 

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

13.05 Salicylic acid 2%/5%/10%/20% 

note From British Association of Dermatologists (BAD) Specials List 2014.

unlicensed Unlicensed

13.04 Salicylic acid 5%, with propylene glycol 47.5% in clobetasol propionate 0.05% (Dermovate®) 

Restricted Item Dermatology recommendation only

note Refer to British Association of Dermatologists Specials List 2014 for further details

unlicensed unlicensed

13.07 Salicylic acid with lactic acid Salactol®

note May be purchased OTC

For palmar/plantar warts, corns, calluses.

03.01.01.01 Salmeterol 

note Prescribe by brand name.

DPI = Serevent Accuhaler

05.03.01 Saquinavir 
10.01.03 Sarilumab Kevzara®
A2.04.01.02 Scandishake ®  

6 x 85g stocked in pharmacy

Chocolate, Strawberry, Vanilla

Unflavoured/Caramel/Banana - not held in stock but available to order through pharmacy

10.01.03 Secukinumab Cosentyx®) (Rheumatology

Rheumatology indications

13.05.03 Secukinumab Cosentyx®) (dermatology
04.09.01 Selegiline Hydrochloride 
09.06.07 Selenium and vitamins A,C and E   Intensive care only
06.01.02.03 Semaglutide Ozempic®

Once weekly formulation.

01.06.02 Senna 
04.03.03 Sertraline 
09.05.02.02 Sevelamer Carbonate 

Only when calcium-containing products not tolerated

09.05.02.02 Sevelamer Hydrochloride  Renagel®

Only when calcium-containing products not tolerated

15.01.02 Sevoflurane 

Restricted Item For children, patients with liver failure or obesity

02.05.01 Sildenafil Revatio®

Restricted Item  Specialist use only. Pulmonary hypertension.

02.06.04 Sildenafil 

Off label use

An option in patients with Raynaud’s phenomenon

07.04.05 Sildenafil 

note First-line PDE5 inhibitor, including post-prostatectomy. Prescribe as generic, on-demand. Regular use not supported (DPC recommendations Aug 2014). 

Green Green for ED

Amber Amber for severe Raynaud's associated with scleroderma (see shared care guideline)

07.04.05 Sildenafil 

Restricted Item Specialised commissioning for paediatrics

11.08.02 Silicone fluid 5700 CS liq 

unlicensed unlicensed

13.07 Silver nitrate ('caustic') 
13.10.01.01 Silver sulfadiazine 1% Flamazine®

note For infected burns and ulcers

05.03.03.02 Simeprevir 
01.01.01 Simeticone infacol®

For use during endoscopy unlicensed Unlicensed

A2.03.01 Similac Alimentum® 

Ordered via main stores

03.09.02 Simple Linctus, BP 
02.12 Simvastatin 
12.04 Sinus Rinse 
08.02.02 Sirolimus 

Red Red for renal transplant
Amber Amber for liver transplant

06.01.02.03 Sitagliptin 
A2.03.01 SMA® 1 ready to feed 

Ordered through main stores

100mls x 24

A2.03.01 SMA® Althera 

Ordered through main stores

450g

A2.03.01 SMA® high energy ready to feed 

Ordered through main stores

100mls x 24

A2.03.01 SMA® lactose free 

Ordered through main stores

430g

18 Snakebite Antivenom Serum Adder
A2.03.01 Sno-Pro® 

Not held in stock but available to order through pharmacy

200ml

09.08.01 Sodium Benzoate  

unlicensed unlicensed

09.02.01.03 Sodium Bicarbonate 
09.02.02.01 Sodium bicarbonate 

Sodium bicarbonate 1.26%, 1.4%, 2.74%, 4.2% intravenous infusion

Sodium bicarbonate 8.4% intravenous infusion

12.01.03 Sodium Bicarbonate 
18 Sodium calcium edetate 
09.02.01.02 Sodium Chloride Slow Sodium®
07.04.04 Sodium chloride 0.9% 
12.02.02 Sodium chloride 0.9% 
13.11.01 Sodium chloride 0.9%  Normal saline

note For wound irrigation. 

Refer to Wound Formulary for further details.

11.99.99.99 Sodium chloride 0.9% (saline) unit dose eye drops Minims

Preservative-free

03.07 Sodium chloride 3% (Hypertonic saline) 

Restricted Item Specialist use only

11.99.99.99 Sodium Chloride 5% eye drops/ eye ointment 

unlicensed Eye ointment unlicensed

03.07 Sodium chloride 7% (Hypertonic saline) 

Prescribe by brand name for CF

09.02.02.01 Sodium Chloride and Glucose Intravenous Infusion 

Sodium chloride 0.18% and glucose 4% intravenous infusion

Sodium chloride 0.45% and glucose 2.5% intravenous infusion

Sodium chloride 0.45% and glucose 5% intravenous infusion

Sodium chloride 0.9% and glucose 5% intravenous infusion

09.02.02.01 Sodium Chloride Intravenous 

Sodium chloride 0.45% intravenous infusion

Sodium chloride 0.9% intravenous infusion

Sodium chloride 5% intravenous infusion

15.03 Sodium citrate 0.3M  

For prevention of aspiration pneumonitis prior to general anaesthesia for emergency caesarean section

01.06.04 Sodium Citrate enema 

Micolette enema (FP10)

06.06.02 Sodium clodronate 
03.03.01 Sodium Cromoglicate 
11.04.02 Sodium cromoglicate 

note First line for allergic conjunctivitis and seasonal keratoconjunctivitis

Unit dose formulation only for patients allergic to preservatives

09.01.01.01 Sodium Feredetate Sytron®
13.10.01.02 Sodium fusidate 2% Fucidin®
05.01.07 Sodium fusidate/fusidic acid 
09.05.02.01 Sodium glycerophosphate 21.6% Glycophos®

unlicensed unlicensed

First line intravenous choice

07.04.04 Sodium hyaluronate Hyacyst®

Restricted Item Urology specialist only

11.08.01 Sodium hyaluronate 

note For use in line with DPC dry eye guidelines (link below)

11.08.02 Sodium hyaluronate 1% Provisc®

Restricted Item Ophthalmology only

note First line for routine cataract surgery cases.

11.08.02 Sodium hyaluronate 1% Healonid®

Restricted Item Ophthalmology only

note Corneal grafts or other corneal surgery

11.08.02 Sodium hyaluronate 1.4% Healonid GV

Restricted Item Ophthalmology only

note Second line for more complex cataract surgery cases

07.04.04 Sodium hyaluronate and sodium chondroitin iAluRil®

Restricted Item Urology specialist only

01.06.07 Sodium hydrogen carbonate / sodium dihydrogen phosphate Lecicarbon A®

As per UHS chronic constipation guidelines

18 Sodium nitrite 
02.05.01 Sodium nitroprusside 

unlicensed unlicensed

Restricted Item  Critical Care and Child Health nephrology only

04.04 Sodium Oxybate Xyrem®

Restricted Item As per NHS England clinical commissioning criteria for use in children (≤18 years).

Adult use (≥19 years) requires IFR submission to CCG.

09.08.01 Sodium Phenylbutyrate 

unlicensed unlicensed

01.06.02 Sodium Picosulfate 
02.13 Sodium Tetradecyl Sulphate Fibro-Vein®
18 Sodium thiosulphate 
04.02.03 Sodium valproate 

unlicensed Agreed locally for ‘off-label’ use in treatment of manic episodes in bipolar disorder instead of valproate semisodium.

Brand prescribing is not necessary for this indication.

 

 

 

04.08.01 Sodium Valproate 

For primary generalised epilepsy (including absences and myoclonus), partial seizures, secondary generalised tonic-clonic seizures

09.02.01.01 Sodium zirconium cyclosilicate Lokelma

For use only in accordance with recommendations in NICE TA599

05.03.03.02 Sofosbuvir 
05.03.03.02 Sofosbuvir with velpatasvir Epclusa®
05.03.03.02 Sofosbuvir/velpatasvir/voxilaprevir Vosevi
10.01.03 Soldium Aurothiomalate Myocrisin®
07.04.02 Solifenacin 
07.04.04 Solution G 
06.05.01 Somatropin 

First line choices are Genotropin or Omnitrope.

08.01.05 Sorafenib 
02.03.02 Sotalol 
02.02.03 Spironolactone 
05.03.01 Stavudine 
13.11.07 Sterile larvae  Maggots

Restricted Item Specialist use only

15.03 Sterile talc kit 

Specialist use only

12.04 Sterimar 

Restricted Item For short-term use after ENT surgery only

04.08.01 Stiripentol Diacomit®

Restricted Item Specialist initiation only.

Amber Initiation Amber Initiation - for the treatment of severe myoclonic epilepsy.

Amber SCG Amber Shared Care Guidelines - for Dravet syndrome in children aged 3 years or older, adolescents and adults, in accordance with NICE guidelines CG137.

01.08 Stoma Care 

Contact the Intestinal Failure Unit on 023 8120 6510

02.10.02 Streptokinase 
05.01.09 Streptomycin  

unlicensed unlicensed

08.01.05 Streptozocin 

unlicensed unlicensed

Locally advanced and metastatic neuroendocrine tumours

01.03.03 Sucralfate 

unlicensed unlicensed 

13.02.02 Sudocrem® 
15.01.06 Sugammadex Bridion®

Restricted Item Consultant anaesthetist use only

13.14 Sugar Paste (thick) 
05.04.07 Sulfadiazine 
05.01.08 Sulfamethoxypyridazine (sulphamethoxypyridazine) 

Restricted Item Dermatology only

unlicensed Unlicensed

01.05.01 Sulfasalazine Gastroenterology
10.01.03 Sulfasalazine EC Salazopyrin EN-Tabs®) (Rheumatology
04.02.01 Sulpiride 
04.02.01 Sulpiride 
04.07.04.01 Sumatriptan 

50mg tablet - first line oral triptan

Injection for migraine, if oral or nasal preparations fail, or cluster headache

08.01.05 Sunitinib 
13.08.01 Sunsense ® Ultra SPF 50+

Borderline substance (ACBS).

09.03 Susoctocog alfa Obizur®

Restricted Item In line with clinical commissioning policy  

15.01.05 Suxamethonium Chloride 
13.05.02 Tacalcitol Curatoderm®
08.02.02 Tacrolimus 

Red Red for renal transplant
Amber Amber for all other indications

Specify brand

Second line for resistant nephrotic syndrome

MR cap for continuation in established patients only

08.02.02 Tacrolimus 

Only for patients already receiving tacrolimus who become nil by mouth

13.05.03 Tacrolimus 

0.03% and 0.1%

13.14 Tacrolimus 

0.1% and 0.3%

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

07.04.05 Tadalafil 

For use if sildenafil not tolerated/effective, or longer duration of action required. Prescribe as generic, on-demand.

Once-daily use and regular use post-prostatectomy not supported (DPC Aug 2014 and Apr 2018).

02.14 Tafamidis Vyndaqel

Restricted Item Specialist use only. NHS England specialised commissioning for treatment of transthyretin amyloid cardiomyopathy in adults in Trusts providing specialised amyloidosis services.

Available via MHRA EAMS application for eligible patients.

Red Triangle Not routinely stocked at UHS. If required, liaise with lead divisional pharmacist.

11.06 Tafluprost 

Not a first line choice.

Preservative-free.

Restricted Item Only for patients allergic/intolerant of preservatives, or high risk for developing allergy.

11.06 Tafluprost with timolol Taptiqom®

Not a first line choice.

Preservative-free.

Restricted Item Only for patients allergic/intolerant of preservatives, or high risk of developing allergy

08.01.05 Talimogene laherparepvec Imlygic®

Observe special precautions for handling and disposal (refer to SPC section 6.6)

08.03.04.01 Tamoxifen 

Restricted Item Liquid restricted for patients unable to swallow tablets

07.04.01 Tamsulosin 
07.04.01 Tamsulosin and Solifenacin Vesomni®

For men not adequately responding to monotherapy

04.07.02 Tapentadol 

Restricted Item Specialist recommendation for third or fourth line use

Liquid for breakthrough pain for patients taking MR tablets only

05.01 Taurolidine  Taurolock®

For use as a line lock in patients on long-term TPN or IV fluids

05.01 Taurolidine, citrate and heparin  TauroLock-Hep500®

For use as a line lock in patients on long-term TPN or IV fluids

05.01.07 Teicoplanin 
04.01.01 Temazepam 
05.01.01.02 Temocillin 

Restricted Item Specialist use only

08.01.05 Temozolomide 
02.10.02 Tenecteplase Metalyse®
05.03.01 Tenofovir disoproxil fumarate 
A2.01.03.02 Tentrini ® 

Not held in stock but available to order through pharmacy

8x 500ml

Paediatric wards only

A2.01.03.04 Tentrini ®energy 

Not held in stock but available to order through pharmacy

8 x 500ml

Paediatric wards only

A2.01.03.02 Tentrini ®Multifibre 

Not held in stock but available to order through pharmacy

8 x 500ml

Paediatric wards only

A2.01.02.01 Tentrini® energy multifibre 

Not held in stock but available to order through pharmacy

8 x 500ml

Paediatric wards only

05.02.05 Terbinafine 
13.10.02 Terbinafine 1% 

note Can be purchased OTC for athlete's foot or Dhobie itch/jock itch.

03.01.01.01 Terbutaline 
07.01.03 Terbutaline 
08.02.04 Teriflunomide 
06.06.01 Teriparatide 

Specialist use only.

In addition to licensed indications, also used for treatment of atypical subtrochanteric fractures.

06.05.02 Terlipressin 
06.01.06 Test Strips Keto-Diastix®

Ketones and glucose

06.01.06 Test Strips Multistix 8SG®

Glucose, protein, pH, ketones, specific gravity, blood, nitrite, leucocytes

06.01.06 Test Strips Multistix SG®

Glucose, protein, blood, ketones, urobiligen, pH, bilirubin, specific gravity

06.01.06 Test Strips Uristix®

Protein and glucose

06.04.02 Testosterone  

unlicensed unlicensed

for hypoactive sexual desire disorder associated with surgically-induced menopause

06.04.02 Testosterone 2%  Tostran®

for proven hypogonadism with marked clinical symptoms

note Multi-dose pump. One press of the canister piston delivers 0.5g of gel containing 10mg testosterone.

06.04.02 Testosterone 20mg/g Testavan®

for proven hypogonadism with marked clinical symptoms.

Preferred brand of testosterone gel locally - DPC Feb 2020.

06.04.02 Testosterone 50mg/5g Testogel®

for proven hypogonadism with marked clinical symptoms

06.04.02 Testosterone enantate 
06.04.02 Testosterone injection Sustanon®

GUM only

06.04.02 Testosterone undecanoate Nebido®

for hypogonadism

14.05.02 Tetanus immunoglobulin 
04.09.03 Tetrabenazine 
11.07 Tetracaine (amethocaine) Minims®
15.02 Tetracaine (Amethocaine) Ametop®
06.05.01 Tetracosactide Synacthen®
03.07 Tezacaftor and ivacaftor Symkevi®

Restricted to patients as per NHS England access agreement

08.02.04 Thalidomide 

Also for renal cell carcinoma

03.01.03 Theophylline 

Prescribe by brand

Slo-Phyllin/Nuelin SA preferred brands at UHS, other brands available for existing patients

09.06.02 Thiamine (vitamin B1) 
15.01.01 Thiopental 
08.01.01 Thiotepa 

For treatment of CNS diffuse large B cell lymphoma

04.08.01 Tiagabine Gabitril®
06.04.01.01 Tibolone 
02.09 Ticagrelor 

For patients temporarily unable to swallow

02.09 Ticagrelor Brilique®
05.01.01.04 Ticarcillin with clavulanic acid 

unlicensed Specialist use only

02.09 Ticlopidine 

unlicensed unlicensed

Restricted Item Specialist use only.

05.01.03 Tigecycline 

unlicensed Specialist use only

13.05.03 Tildrakizumab Ilumetri®
11.06 Timolol 

First line beta-blocker.

Restricted Item Unit dose drops/gel only for patients allergic/intolerant of preservative, or high risk of developing allergy

11.06 Timolol Timoptol-LA®

Restricted Item Only for patients with compliance problems with twice-daily formulations

11.06 Timolol preservative-free Eysano®

note Consider as a more cost effective alternative to timolol unit dose eye drops

Restricted Item Only for patients allergic/intolerant of preservative, or high risk of developing allergy

02.08.01 Tinzaparin 

Restricted Item unlicensed Specialist use off label in paediatrics ONLY for prophylaxis or treatment of thromboembolic disorders in long term/Homecare patients with no necessity to remain in hospital (refer to Southampton Children's Hospital guidelines).

Not for use in adults (enoxaparin is LMWH of choice at UHS for adults).

Red Triangle Multidose vials contain 10mg/ml of the preservative benzyl alcohol: may cause toxic and anaphylactoid reactions in infants and children up to 3 years old. Where possible use alternative CIVAS enoxaparin syringes in neonates.

08.01.03 Tioguanine 
03.01.02 Tiotropium 

Restricted Item In UHS initiated by respiratory centre only.

note Prescribing by brand name recommended

Inhalation powder caps licensed for COPD only, not for asthma.

03.01.04 Tiotropium and olodaterol Spiolto Respimat®

note Prescribing by brand name recommended

02.09 Tirofiban Aggrastat®
02.11 Tisseel® kit 

Restricted Item Specialist use only

08.01.05 Tivozanib 
10.02.02 Tizanidine 
05.01.04 Tobramycin 

Restricted Item Dry powder inhaler specialist use only

05.01.04 Tobramycin 

Restricted Item Specialist use only

10.01.03 Tocilizumab RoActemra®

unlicensed Also used off-label for toxicities associated with CAR-T cell therapy

 

Restricted Item Not for use in Covid-19 treatment outside of clinical trials. Seek further advice from infection control specialist/pharmacy team.

01.05.03 Tofacitinib XELJANZ®
10.01.03 Tofacitinib XELJANZ®
06.01.02.01 Tolbutamide 
04.09.01 Tolcapone Tasmar®

Restricted Item Specialist initiation.

Only when entacapone or opicapone are inappropriate

07.04.02 Tolterodine 

note First line for urinary incontinence (refer to local guidelines and NICE CG171)

07.04.02 Tolterodine 

Restricted Item Only if problems with compliance/tolerance of immediate-release preparation

06.05.02 Tolvaptan Jinarc®

Restricted Item Specialist use only

04.07.04.02 Topiramate migraine prophylaxis
04.08.01 Topiramate epilepsy
08.01.05 Topotecan 
08.01.05 Trabectedin 
04.07.02 Tramadol 

Inj only for patients who are NBM

04.07.02 Tramadol 

Not a first line option

08.01.05 Trametinib 
02.11 Tranexamic Acid 

For menorrhagia

02.11 Tranexamic Acid 
02.11 Tranexamic acid 5% mouthwash  

unlicensed Unlicensed special for use in post oral surgery bleeding

10.03.02 Transvasin® 

Restricted Item For use in the respiratory centre only, prior to capillary blood gas sampling

Contains: Tetrahydrofurfuryl salicylate 14%, ethyl nicotinate 2%, hexyl nicotinate 2%

08.01.05 Trastuzumab 
08.01.05 Trastuzumab emtansine 
11.06 Travoprost Travatan®

Not a first-line choice.

Restricted Item Only for patients with allergy to benzalkonium chloride. Prescribe by brand name as other brands may contain benzalkonium chloride.

11.06 Travoprost with timolol DuoTrav®

Not a first-line choice.

Restricted Item Only for patients with allergy to benzalkonium chloride. Prescribe by brand name as other brands may contain benzalkonium chloride.

04.03.01 Trazodone 

For agitation in older people with dementia

11.08.01 Trehalose/sodium hyaluronate Thealoz Duo®

note To be used in line with DPC dry eye guidelines (link below).

08.01.05 Tretinoin 
13.04 Tri-Adcortyl® 

note Contains triamcinolone, gramicidin, neomycin and nystatin 

Restricted Item ENT only

unlicensed unlicensed

10.01.02.02 Triamcinolone Acetonide 

Adcortyl or Kenalog depending on volume

11.04.01 Triamcinolone acetonide Intracinol®

Restricted Item  Specialist ophthalmology use only.

unlicensed Medical device.

Approved for opacification of the vitreous humour in eye surgery and treatment and prevention of macular oedema in inflammatory eye conditions (off-label).

10.01.02.02 Triamcinolone hexacetonide 

Restricted Item For paediatric rheumatology

12.01.01 Triamcinolone/gramicidin/neomycin/nystatin Tri-Adcortyl®

unlicensed unlicensed

Restricted Item ENT use only for short course treatment

09.08.01 Trientine  

Restricted Item Specialist use only. For treatment of Wilson's disease only in accordance with NHS England Clinical Commissioning Policy.

Red Triangle Not routinely stocked at UHS. If required please liaise with divisional lead pharmacist. 

[N.B. Available as trientine dihydrochloride 300mg capsules and trientine tetrahydrochloride (Cuprior) 150mg tablets. NHS England confirm that both formulations will be commissioned]

04.02.01 Trifluoperazine 
08.01.03 Trifluridine and tipiracil 
04.09.02 Trihexyphenidyl 
05.01.08 Trimethoprim 
05.04.08 Trimethoprim 
06.07.02 Triptorelin acetate Gonapeptyl Depot®

Restricted Item This strength restricted to Child Health only

06.07.02 Triptorelin acetate/pamoate 

Restricted Item Red formulary status for fertility treatment (off label use). Specialist prescribing only.

08.03.04.02 Triptorelin acetate/pamoate 
11.05 Tropicamide Minims®

Preservative-free.

07.04.02 Trospium 

note May also be used for treatment of hyperhidrosis (off-label use).

06.07.02 Ulipristal Esmya®

Restricted Item An option for pre-operative treatment of uterine fibroids or for intermittent treatment of uterine fibroids where first line therapies are inappropriate in line with MHRA guidance and liver function monitoring.

07.03.05 Ulipristal acetate EllaOne®

An option up to 120 hours postunprotected sexual intercourse

03.01.02 Umeclidinium Incruse Ellipta®

note Prescribing by brand name recommended

Licensed for COPD only, not for asthma

03.01.04 Umeclidinium and vilanterol Anoro Ellipta®

note Prescribing by brand name recommended

13.02.01 Unguentum M® 

note Consider Zeroguent as a more cost effective alternative

01.07.02 Uniroid HC 
13.02.01 Urea 10% 

e.g. Eucerin Intensive® , Calmurid®

13.02.01 Urea 25% Dermatonics Once®

For use in podiatry only

13.02.01 Urea 25% Allpresan® Diabetic

For use in podiatry only

02.10.02 Urokinase 

For clearing blocked lines/catheters and treatment of empyema (off-label) only

01.09.01 Ursodeoxycholic acid 
01.05.03 Ustekinumab Stelara®) (Gastroenterology
13.05.03 Ustekinumab Stelara®) (dermatology

note 45mg, 90mg injections (130mg not licensed for dermatology indications).

13.08.01 Uvistat ® SPF 30

Borderline substance (ACBS).

05.03.02.01 Valaciclovir 
05.03.02.02 Valganciclovir 
05.01.07 Vancomycin 

Injection only to be used orally when capsules are unable to be given 

05.01.07 Vancomycin 
04.10.02 Varenicline Champix®

As part of a smoking cessation programme.

14.04 Varicella Zoster vaccine (live) Zostavax®

Specialist prescribed for severe, intractable, recurrent herpes zoster infection

14.05.02 Varicella-Zoster immunoglobulin VZIG

Microbiology request only

14.04 Varicella-zoster vaccine 
06.05.02 Vasopressin 
15.01.05 Vecuronium Norcuron®
01.05.03 Vedolizumab Entyvio®

June 2020: Subcutaneous formulation supported by District Prescribing Committee for use as an alternative to IV infusion in eligible patients who meet NICE TA criteria

08.01.05 Vemurafenib 
08.01.05 Venetoclax Venclyxto®
04.03.04 Venlafaxine 

A third line antidepressant

04.03.04 Venlafaxine XL 225mg 

A third line antidepressant

02.03.02 Verapamil  
02.03.02 Verapamil  
02.06.02 Verapamil 
02.06.02 Verapamil 
11.08.02 Verteporfin  Visudyne®
04.08.01 Vigabatrin Sabril®
08.01.04 Vinblastine 
08.01.04 Vincristine  
08.01.04 Vinorelbine 
A2.01.02.01 Vital® 1.5kcal 

Not held in stock but available to order through pharmacy

200ml - Vanilla

09.06.07 Vitamin and mineral supplements Forceval Soluble®

For adults with poor swallowing, who are nil by mouth or who require medicine administration through an enteral feeding tube

09.06.07 Vitamin and mineral supplements Ketovite®
09.06.07 Vitamin and mineral supplements Sanatogen A-Z Complete®
09.06.07 Vitamin and mineral supplements Forceval Junior soluble®
09.06.02 Vitamin B Tablets, Compound Strong 
09.06.01 Vitamins A and D 
09.06.02 Vitamins B and C  Pabrinex®
11.99.99.99 Viteyes 2® Formula 

Restricted Item Restricted use – Secondary care specialist recommendation for patients who have advanced (category 4) AMD in one eye only.

03.01.05 Volumatic ® 
05.02.01 Voriconazole 

Restricted Item Specialist use only

04.03.04 Vortioxetine 

Not a first line antidepressant.

02.08.02 Warfarin 
09.02.02.01 Water for Injection 
13.02.01 White Soft Paraffin  
A2.03.01 Wysoy ® (SMA) 

Ordered via main stores

12.02.02 Xylometazoline Otrivine®
01.07.02 Xyloproct ® 

Local anaesthetic plus steroid

14.04 Yellow fever vaccine (Live) 
05.03.04 Zanamivir Dectova®

For treatment of complicated and potentially life-threatening influenza A or B virus infection in accordance with official guidance

05.03.04 Zanamivir  

Restricted Item In line with NICE TAs or pandemic flu

13.02.01 ZeroAQS® 

note Similar to aqueous cream but does not contain SLS. Suitable for use as leave-on emollient or soap substitute.

13.02.01 Zerobase® 

Similar to Diprobase cream

13.02.01 Zerocream ® 

note Also suitable for use as a soap substitute.

Similar to E45 cream.

13.02.01 Zeroderm® 

note Also suitable for use as a soap substitute or bath additive.

Similar to Epaderm ointment.

13.02.01 Zeroguent®  

note Similar to Unguentum M cream

13.02.01.01 Zerolatum® Emollient 

note Fragrance-free. Similar to Oilatum bath additive.

05.03.01 Zidovudine 
05.03.01 Zidovudine/lamivudine 
13.02.02 Zinc and Castor Oil 

First line barrier preparation

13.05 Zinc and salicylic acid Lassar's paste, half strength

note From British Association of Dermatologists (BAD) Specials List 2014

unlicensed Unlicensed

Where other barrier treatments ineffective

13.05 Zinc and salicylic acid BP Lassar's paste
13.05.01 Zinc paste and ichthammol Ichthopaste
09.05.04 Zinc Sulfate Solvazinc®
09.05.04 Zinc Sulfate 

unlicensed unlicensed

06.06.02 Zoledronic acid  

Specialist use only

06.06.02 Zoledronic acid 

Specialist use only

Used in cancer care in preference to pamidronate disodium or sodium clodronate.

 unlicensed 'Off label' use for post-menopausal women with breast cancer who are assessed by a specialist to be at sufficient risk of breast cancer recurrence. Refer to DPC shared care guidance: Adjuvant Bisphosphonates for Early Breast Cancer Feb 2018

04.07.04.01 Zolmitriptan  

Useful if patients vomit

04.08.01 Zonisamide Zonegran®
04.01.01 Zopiclone 
04.02.01 Zuclopenthixol acetate Clopixol Acuphase®
04.02.02 Zuclopenthixol decanoate Clopixol®

note For deep intramuscular injection

Southampton Joint Formulary